Sunitinib Malate | SU 11248 Malate;Sunitinib (malate);SU11248 | 苹果酸苏尼替尼 | VEGFR | PDGFR | c-Kit

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

产品名称	c-Kit ↓ ↑	其他靶点	纯度
Tyrphostin AG1296	+ c-Kit (Swiss 3T3), IC50: 1.8 μM	PDGFR	99%+
Masitinib	+ Kit, IC50: 200 nM		99%+
Motesanib Diphosphate	+++ Kit, IC50: 8 nM		99%+
Ki8751	++ c-Kit, IC50: 40 nM		99%+
Tivozanib	++ c-Kit, IC50: 78 nM		99%+
Pazopanib	+ c-Kit, IC50: 140 nM		99%
Sitravatinib	+++ Kit, IC50: 6 nM		99%+
Pexidartinib	+++ Kit, IC50: 10 nM		99%+
Lactate	++++ c-Kit, IC50: 2 nM	FLT3	85%
Amuvatinib	+++ c-Kit (D816H), IC50: 10 nM		99%+
Imatinib Mesylate	+ c-Kit, IC50: 100 nM	PDGFR	99%
AZD2932	+++ c-Kit, IC50: 9 nM		99%+
Axitinib	++++ Kit, IC50: 1.7 nM		99%+
Dovitinib	++++ c-Kit, IC50: 2 nM	FLT3	99%+
Sunitinib	✔	FLT3	98%
OSI-930	+ Kit, IC50: 80 nM		99%+
Telatinib	++++ c-Kit, IC50: 1 nM		99%+
Dasatinib monohydrate	++ c-Kit (wt), IC50: 79 nM c-Kit (D816V), IC50: 37 nM	Src	99%+
Dasatinib	++ c-Kit (D816V), IC50: 37 nM c-Kit (wt), IC50: 79 nM	Src	99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

产品名称	PDGFR ↓ ↑	PDGFRα ↓ ↑	PDGFRβ ↓ ↑	其他靶点	纯度
Tyrphostin A9	+ PDGFR, IC50: 0.5 μM			EGFR	98%
Tyrphostin AG1296					99%+
Motesanib Diphosphate	++ PDGFR, IC50: 84 nM				99%+
Pazopanib	++ PDGFR, IC50: 84 nM				99%
Imatinib	+ PDGFR, IC50: 100 nM			c-Kit	99%+
Imatinib Mesylate	+ PDGFR, IC50: 100 nM			c-Kit	99%
Sennoside B	✔				99%+
PP121	++++ PDGFR, IC50: 2 nM			VEGFR,mTOR	99%+
Crenolanib		++++ PDGFRα, Kd: 2.1 nM	++++ PDGFRβ, Kd: 3.2 nM		99%+
Masitinib		+ PDGFRα, IC50: 540 nM	+ PDGFRβ, IC50: 800 nM		99%+
Ki8751		++ PDGFRα, IC50: 67 nM		c-Kit	99%+
Tivozanib		++ PDGFRα, IC50: 40 nM	++ PDGFRβ, IC50: 49 nM		99%+
Ponatinib		++++ PDGFRα, IC50: 1.1 nM			99%+
Amuvatinib		++ PDGFRα (V561D), IC50: 40 nM			99%+
Axitinib		+++ PDGFRα, IC50: 5.0 nM	++++ PDGFRβ, IC50: 1.6 nM		99%+
CP-673451		+++ PDGFRα, IC50: 10 nM	++++ PDGFRβ, IC50: 1 nM		99%+
Telatinib		+++ PDGFRα, IC50: 15 nM		c-Kit	99%+
Nintedanib		++ PDGFRα, IC50: 59 nM	++ PDGFRβ, IC50: 65 nM		99+%
Avapritinib		++++ PDGFRα (D842V), IC50: 0.5 nM			99%+
MK-2461			+++ PDGFRβ, IC50: 22 nM		99%+
Lactate			+++ PDGFRβ, IC50: 27 nM	c-Kit,FLT3	85%
Linifanib			++ PDGFRβ, IC50: 66 nM		99%+
AZD2932			+++ PDGFRβ, IC50: 4 nM	c-Kit	99%+
Dovitinib			+++ PDGFRβ, IC50: 27 nM	c-Kit,FLT3	99%+
Sorafenib			++ mPDGFRβ, IC50: 57 nM PDGFRβ, IC50: 57 nM		99%
Sunitinib			++++ PDGFRβ , IC50: 2 nM	FLT3	98%
Orantinib			+++ PDGFRβ, Ki: 8 nM		99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

产品名称	VEGFR1 ↓ ↑	VEGFR2 ↓ ↑	VEGFR3 ↓ ↑	其他靶点	纯度
Motesanib Diphosphate	++++ VEGFR1, IC50: 2 nM	++++ VEGFR2, IC50: 3 nM VEGFR2/Flk1, IC50: 3 nM	+++ VEGFR3, IC50: 6 nM	RET,PDGFR	99%+
Tivozanib	++ VEGFR1, IC50: 30 nM	+++ VEGFR2, IC50: 6.5 nM	++ VEGFR3, IC50: 15 nM		99%+
Brivanib	+ VEGFR1, IC50: 380 nM	++ Flk1, IC50: 25 nM VEGFR2, IC50: 25 nM			99%+
Regorafenib	+++ VEGFR1, IC50: 13 nM	+++ VEGFR2, IC50: 4.2 nM	+ VEGFR3, IC50: 46 nM	RET	98%
Pazopanib	+++ VEGFR1, IC50: 10 nM	++ VEGFR2, IC50: 30 nM	+ VEGFR3, IC50: 47 nM	c-Kit,FGFR,PDGFR	99%
Sitravatinib	+++ VEGFR1 (FLT1), IC50: 6 nM	+++ VEGFR2 (KDR), IC50: 5 nM	++++ VEGFR3 (FLT4), IC50: 2 nM		99%+
Foretinib	+++ VEGFR1/FLT1, IC50: 6.8 nM	++++ KDR, IC50: 0.86 nM	++++ VEGFR3/FLT4, IC50: 2.8 nM	Tie-2	99%+
MGCD-265 analog	++++ VEGFR1, IC50: 3 nM	++++ VEGFR2, IC50: 3 nM	++++ VEGFR3, IC50: 4 nM	Tie-2	99%+
Lactate	+++ VEGFR1/FLT1, IC50: 10 nM	+++ VEGFR2/Flk1, IC50: 13 nM	+++ VEGFR3/FLT4, IC50: 8 nM	c-Kit,FLT3	85%
AEE788	+ FLT1, IC50: 59 nM	+ KDR, IC50: 77 nM		EGFR	98+%
Linifanib	++++ VEGFR1/FLT1, IC50: 3 nM	++++ VEGFR2/KDR, IC50: 4 nM	+ VEGFR3/FLT4, IC50: 190 nM	FLT3	99%+
Vatalanib 2HCl	+ VEGFR1/FLT1, IC50: 77 nM	++ VEGFR2/Flk1, IC50: 270 nM VEGFR2/KDR, IC50: 37 nM	+ VEGFR3/FLT4, IC50: 660 nM	c-Kit,c-Fms	99%+
Axitinib	++++ VEGFR1/FLT1, IC50: 0.1 nM	++++ VEGFR2/Flk1, IC50: 0.18 nM VEGFR2/KDR, IC50: 0.2 nM			99%+
Dovitinib	+++ VEGFR1/FLT1, IC50: 10 nM	+++ VEGFR2/Flk1, IC50: 13 nM	+++ VEGFR3/FLT4, IC50: 8 nM	c-Kit,FLT3	99%+
ZM 306416	+ VEGFR1, IC50: 0.33 μM			Src	99%+
KRN-633	+ VEGFR1, IC50: 170 nM	+ VEGFR2, IC50: 160 nM	+ VEGFR3, IC50: 125 nM	c-Kit,BTK	99%+
OSI-930	+++ FLT1, IC50: 8 nM	+++ KDR, IC50: 9 nM			99%+
Lenvatinib	++ VEGFR1/FLT1, IC50: 22 nM	++++ VEGFR2/KDR, IC50: 4.0 nM	+++ VEGFR3/FLT4, IC50: 5.2 nM		98%
NVP-BAW2881	+ hVEGFR1, IC50: 820 nM	+++ hVEGFR2, IC50: 9 nM mVEGF2, IC50: 165 nM	+ hVEGFR3, IC50: 420 nM		99%+
Cediranib	+++ VEGFR1/FLT1, IC50: 5 nM	++++ VEGFR2/KDR, IC50: 0.5 nM		c-Kit	99%+
Nintedanib	++ VEGFR1, IC50: 34 nM	+++ VEGFR2, IC50: 13 nM	+++ VEGFR3, IC50: 13 nM	FLT3	99+%
BMS-794833		++ VEGFR2, IC50: 15 nM			99%+
SKLB1002		++ VEGFR2, IC50: 32 nM			99%+
Cabozantinib S-malate		++++ VEGFR2/KDR, IC50: 0.035 nM			99+%
Ki8751		++++ VEGFR2, IC50: 0.9 nM		c-Kit	99%+
SU 5402		++ VEGFR2, IC50: 20 nM			99%+
Rivoceranib Mesylate		++++ VEGFR2, IC50: 1 nM		RET	99%+
Ponatinib		++++ VEGFR2, IC50: 1.5 nM			99%+
LY2874455		+++ VEGFR2, IC50: 7 nM			99%+
ZM323881 HCl		++++ VEGFR2, IC50: <2 nM			98%
AZD2932		+++ VEGFR-2, IC50: 8 nM		c-Kit	99%+
Cabozantinib		++++ VEGFR2/KDR, IC50: 0.035 nM			98%
Sorafenib		++ VEGFR2, IC50: 90 nM VEGFR2/Flk1, IC50: 90 nM			99%
CYC-116		++ VEGFR2, Ki: 44 nM		FLT3	99%+
Golvatinib		++ VEGFR2, IC50: 16 nM			99%+
Sunitinib		+ VEGFR2 , IC50: 80 nM		FLT3	98%
RAF265		++ VEGFR2, EC50: 30 nM			99%+
PD173074					99%+
BFH772		++++ VEGFR2, IC50: 3 nM			99%+
Semaxinib		+ VEGFR2/Flk1, IC50: 1.23 μM			98%
Vandetanib		++ VEGFR2, IC50: 40 nM	+ VEGFR3, IC50: 110 nM	EGFR	99%+
SAR131675			++ VEGFR3, IC50: 23 nM		99%+
ENMD-2076		+ VEGFR2/KDR, IC50: 58.2 nM	++ VEGFR3/FLT4, IC50: 15.9 nM	RET,FLT3	98%
Telatinib		+++ VEGFR2, IC50: 6 nM	++++ VEGFR3, IC50: 4 nM	c-Kit	99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

细胞系	检测类型	检测时间	活动说明	数据源
3T3	Kinase Assay		Inhibition of PDGF-induced BrdU incorporation with IC50 of 0.007 μM	12646019
3T3	Growth Inhibition Assay		Inhibition of Platelet-derived growth factor induced 3T3 cell proliferation with IC50 of 0.01 μM	12646019
3T3	Function Assay		Inhibition of Vascular endothelial growth factor receptor with IC50 of 0.05 μM	12646019
3T3	Kinase Assay	20 min	Cellular inhibition of VEGF induced human KDR phosphorylation with IC50 of 0.022 μM	16162008

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00663559	Carcinoma Renal Cells	Phase 2	Completed	-	Spain ... 展开 >> Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital CLINIC Barcelona, Spain, 08036 Hospital Reina Sofía Córdoba, Spain, 14004 Hospital de Jaén Jaén, Spain, 23007 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital lozano Blesa Zaragoza, Spain, 50009 收起 <<
NCT03097601	-		Active, not recruiting	December 30, 2019	France ... 展开 >> Centre Antoine LACASSAGNE Nice, France, 06189 收起 <<
NCT01243359	Clear Cell Renal Cell Carcinom... 展开 >>a Recurrent Renal Cell Cancer Stage I Renal Cell Cancer Stage II Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Unspecified Adult Solid Tumor, Protocol Specific 收起 <<	Phase 1	Completed	-	United States, Maryland ... 展开 >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 <<
NCT00372775	Non-Small Cell Lung Cancer	Phase 2	Completed	-	United States, Connecticut ... 展开 >> Pfizer Investigational Site Norwalk, Connecticut, United States, 06856 United States, Florida Pfizer Investigational Site Cocoa Beach, Florida, United States, 32931 Pfizer Investigational Site Merritt Island, Florida, United States, 32952 Pfizer Investigational Site Titusville, Florida, United States, 32796 United States, Missouri Pfizer Investigational Site Creve Coeur, Missouri, United States, 63141 Pfizer Investigational Site St. Louis, Missouri, United States, 63110-1094 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 Pfizer Investigational Site St. Peters, Missouri, United States, 63376 United States, New Jersey Pfizer Investigational Site Basking Ridge, New Jersey, United States, 07920 United States, New York Pfizer Investigational Site Commack, New York, United States, 11725 Pfizer Investigational Site New York, New York, United States, 10022 United States, Pennsylvania Pfizer Investigational Site Sayre, Pennsylvania, United States, 18840 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78705 Pfizer Investigational Site Austin, Texas, United States, 78745 Pfizer Investigational Site Austin, Texas, United States, 78758 Pfizer Investigational Site Austin, Texas, United States, 78759 Pfizer Investigational Site Round Rock, Texas, United States, 78664 France Pfizer Investigational Site Pessac, Be1 04495, France, 33604 Pfizer Investigational Site Marseille Cedex 09, France, 13009 Pfizer Investigational Site Saint-Priest en Jarez Cedex, France, 42271 Pfizer Investigational Site Toulouse cedex 9, France, 31059 Italy Pfizer Investigational Site Bologna, Italy, 40139 Pfizer Investigational Site Genova, Italy, 16132 Pfizer Investigational Site Orbassano (TO), Italy, 10043 Pfizer Investigational Site Roma, Italy, 00151 Spain Pfizer Investigational Site Madrid, Spain, 28046 Pfizer Investigational Site Valencia, Spain, 46014 收起 <<
NCT00399152	Renal Cancer ... 展开 >>GIST 收起 <<	Phase 1	Completed	-	-
NCT00864864	Glioblastoma ... 展开 >>Brain Tumor 收起 <<	Early Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT01005472	Metastatic Melanoma	Phase 1	Completed	-	United States, California ... 展开 >> University of California Los Angeles (UCLA) Los Angeles, California, United States, 90095 收起 <<
NCT02402062	Neuroendocrine Tumors ... 展开 >> Pancreatic Neoplasms 收起 <<	Phase 2	Active, not recruiting	June 2019	Spain ... 展开 >> Institut Catalá d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Provincial de Castellón Castelló, Valencia, Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario Virgen de las Nieves Granada, Spain, 18014 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 收起 <<
NCT00699374	Carcinoma, Hepatocellular	Phase 3	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00699374	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00372775	-		Completed	-	-
NCT00577382	-		Completed	-	-
NCT00577382	Mucosal Lentiginous Melanoma ... 展开 >> Acral Lentiginous Malignant Melanoma 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Washington University in St. Louis St. Louis, Missouri, United States, 63110 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37212 收起 <<
NCT00422344	Renal Cell Carcinoma ... 展开 >> Kidney Cancer 收起 <<	Phase 1	Completed	-	United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10021 收起 <<
NCT00961571	Metastatic Colorectal Cancer	Phase 2	Terminated(Unanticipated side ... 展开 >>effects and futility) 收起 <<	-	United States, District of Col... 展开 >>umbia Lombardi Cancer Center at Georgetown University Washington, District of Columbia, United States, 20007 收起 <<
NCT01308034	Non GIST Sarcomas	Phase 1	Completed	-	France ... 展开 >> Institut Bergonié Bordeaux, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France, 69373 CHU La Timone Marseille, France Institut de Cancérologie de l'ouest Saint Herblain, France Institut Gustave Roussy Villejuif, France 收起 <<
NCT00499473	-		Completed	-	-
NCT01462695	Childhood Cerebellar Anaplasti... 展开 >>c Astrocytoma Childhood Cerebral Anaplastic Astrocytoma Childhood Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Subependymal Giant Cell Astrocytoma 收起 <<	Phase 2	Completed	-	-
NCT00499473	Adult Anaplastic Astrocytoma ... 展开 >> Adult Diffuse Astrocytoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Adult Oligodendroglioma Adult Pineal Gland Astrocytoma 收起 <<	Phase 2	Completed	-	United States, Ohio ... 展开 >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 <<
NCT01462695	-		Completed	-	-
NCT01064310	Carcinoma, Renal Cell	Phase 3	Completed	-	-
NCT00392444	Advanced Malignant Mesotheliom... 展开 >>a Recurrent Malignant Mesothelioma 收起 <<	Phase 2	Completed	-	Canada, Ontario ... 展开 >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 收起 <<
NCT01064310	-		Completed	-	-
NCT01402817	Neurofibromatosis ... 展开 >> NF1 Plexiform Neurofibromas 收起 <<	Phase 2	Terminated(1 patient died of u... 展开 >>ncertain cause but possibly related to drug.) 收起 <<	-	United States, Indiana ... 展开 >> Riley Hospital for Children at IU Health Indianapolis, Indiana, United States, 46202 收起 <<
NCT03025893	Glioblastoma Multiforme ... 展开 >> Glioblastoma, Adult Glioblastoma Recurrent Brain Tumor GBM 收起 <<	Phase 2 Phase 3	Recruiting	January 2020	Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Netherlands Contact: Cyrillo G Brahm, MD +31 20 444 4321 Principal Investigator: Henk WM Verheul, MD PhD Sub-Investigator: Cyrillo G Brahm, MD University Medical Center Groningen Not yet recruiting Groningen, Netherlands Contact: Cyrillo G Brahm, MD PhD Principal Investigator: Annemiek ME Walenkamp, MD PhD Sub-Investigator: Cyrillo G Brahm, MD 收起 <<
NCT01122615	Renal Cell Cancer ... 展开 >> Kidney Cancer 收起 <<	Phase 1	Completed	-	United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT02928575	Glioblastoma Multiforme	Phase 2	Unknown	June 2017	Canada, Alberta ... 展开 >> Tom Baker Cancer Center and University of Calgary Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Jacob Easaw, MD PhD FRCPC 403-521-3446 Jay.Easaw@albertahealthservices.ca Canada, Quebec McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Bassam Abdulkarim, MD PhD FRCPC 514-934-1934 ext 43915 bassam.abdulkarim@mcgill.ca 收起 <<
NCT01158222	Clear Cell Renal Cell Carcinom... 展开 >>a Stage IV Renal Cell Cancer 收起 <<	Phase 2	Completed	-	United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 <<
NCT01158222	-		Completed	-	-
NCT00392444	-		Completed	-	-
NCT00656669	Breast Cancer	Not Applicable	Completed	-	United States, Indiana ... 展开 >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 收起 <<
NCT00618124	Solid Tumors ... 展开 >>Breast Cancer Neoplasms 收起 <<	Phase 1	Completed	-	United States, Indiana ... 展开 >> Pfizer Investigational Site Indianapolis, Indiana, United States, 46202 United States, New Mexico Pfizer Investigational Site Albuqurque, New Mexico, United States, 87131 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37203 收起 <<
NCT00961571	-		Terminated(Unanticipated side ... 展开 >>effects and futility) 收起 <<	-	-
NCT00843037	Paraganglioma ... 展开 >> Pheochromocytoma 收起 <<	Phase 2	Completed	-	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario University Health Network, Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hôpital Notre-Dame du CHUM Montreal, Quebec, Canada, H2L 4M1 Netherlands University Medical Centre Groningen Groningen, Netherlands 收起 <<
NCT00656669	-		Completed	-	-
NCT02164240	Gastrointestinal Stromal Tumor	Phase 1	Active, not recruiting	May 2020	United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT00631618	Metastatic Melanoma	Phase 2	Completed	-	United States, California ... 展开 >> California Pacific Medical Center San Francisco, California, United States, 94115 收起 <<
NCT00967603	Pancreatic Cancer	Phase 2	Completed	-	Italy ... 展开 >> San Raffaele Scientific Institute Milan, Italy, 20132 收起 <<
NCT00299741	Prostate Cancer	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel-Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT00615446	Solid Tumors	Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 收起 <<
NCT00299741	-		Completed	-	-
NCT02386111	Carcinoma, Renal Cell ... 展开 >> Kidney Diseases Kidney Neoplasms Urogenital Neoplasms Urologic Diseases Urologic Neoplasms Neoplasms Neoplasms by Histologic Type Clear-cell Metastatic Renal Cell Carcinoma 收起 <<	Phase 1	Terminated(Portfolio re-priori... 展开 >>tization) 收起 <<	-	United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California UC Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 UCSF Helen Diller Comprehensive Cancer Center San Francisco, California, United States, 94158 United States, District of Columbia George Washington University-Medical Faculty Associates Washington, District of Columbia, United States, 20037 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Nebraska Nebraska Cancer Specialists Omaha, Nebraska, United States, 68130 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 <<
NCT02058901	Solid Tumors	Phase 1	Recruiting	December 2017	Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Netherlands, 1081HV Contact: Henk MW Verheul, MD, PhD +31-20-4444321 h.verheul@vumc.nl Principal Investigator: Henk MW Verheul, MD, PhD 收起 <<
NCT01740154	-		Terminated(Slow Accrual)	-	-
NCT01402817	-		Terminated(1 patient died of u... 展开 >>ncertain cause but possibly related to drug.) 收起 <<	-	-
NCT00526656	Bladder Cancer	Phase 2	Completed	-	United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 <<
NCT01740154	Fatigue Recur... 展开 >>rent Renal Cell Cancer Stage IV Renal Cell Cancer 收起 <<	Not Applicable	Terminated(Slow Accrual)	-	United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 <<
NCT00787787	Adult Primary Hepatocellular C... 展开 >>arcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer 收起 <<	Phase 2	Terminated	-	United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 <<
NCT00270413	Metastatic Breast Cancer	Phase 2	Completed	-	Belgium ... 展开 >> Imelda Bonheiden Bonheiden, Belgium AZ st-jan brugge Brugge, Belgium AZ VUB Brussels, Belgium UCL Brussels, Belgium Charleroi Charleroi, Belgium UZ Gent Gent, Belgium, 9000 ZOL Hasselt, Belgium UZ Leuven Leuven, Belgium, 3000 Liege sart-tilman Liege, Belgium Namur st-elisabeth Namur, Belgium St-Elisabeth Turnhout Turnhout, Belgium AZ st-augustinus Wilrijk, Belgium Mont-Godinne Yvoir, Belgium 收起 <<
NCT00730353	Esophageal Cancer	Phase 2	Completed	-	United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Rush-Presbyterian St. Luke's Medical Center Chicago, Illinois, United States, 60612 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 IN Onc/Hem Associates Indianapolis, Indiana, United States, 46202 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Monroe Medical Associates Munster, Indiana, United States, 46321 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Ohio Ireland Cancer Center - University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 收起 <<
NCT00388037	-		Completed	-	-
NCT00388037	Recurrent Fallopian Tube Cance... 展开 >>r Recurrent Ovarian Epithelial Cancer Recurrent Primary Peritoneal Cavity Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Epithelial Cancer Stage IIIA Primary Peritoneal Cavity Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Epithelial Cancer Stage IIIB Primary Peritoneal Cavity Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Epithelial Cancer Stage IIIC Primary Peritoneal Cavity Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Epithelial Cancer Stage IV Primary Peritoneal Cavity Cancer 收起 <<	Phase 2	Completed	-	Canada, Ontario ... 展开 >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 收起 <<
NCT01743300	Healthy	Phase 1	Completed	-	-
NCT00753727	Soft Tissue Sarcoma	Phase 1 Phase 2	Unknown	March 2016	Australia, Victoria ... 展开 >> Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3002 Contact: Ania Matera +61396563661 Ania.Matera@petermac.org Contact: Sally Whyte, PhD +61396563605 sally.whyte@petermac.org Principal Investigator: David Thomas, MB BS PhD 收起 <<
NCT00788060	Renal Cell Carcinoma	Phase 1	Completed	-	United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27705 收起 <<
NCT00768144	-		Completed	-	-
NCT01100177	Glioblastoma	Phase 2	Completed	-	Spain ... 展开 >> Grupo Español de Investigacion en Neurooncologia Madrid, Spain, 28001 收起 <<
NCT00787787	-		Terminated	-	-
NCT00329043	Prostate Cancer	Phase 2	Active, not recruiting	May 2019	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00730353	-		Completed	-	-
NCT00616109	-		Completed	-	-
NCT00378911	Recurrent Uterine Sarcoma ... 展开 >> Uterine Leiomyosarcoma 收起 <<	Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 收起 <<
NCT00768144	Ovarian Cancer ... 展开 >> Fallopian Tube Cancer Peritoneal Cancer 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 <<
NCT01215578	Neuroendocrine Tumors ... 展开 >> Pancreatic Neoplasms Advanced Disease Sunitinib 收起 <<	Phase 2	Terminated(lack of recruitemen... 展开 >>t) 收起 <<	-	France ... 展开 >> Hôpital Beaujon Clichy, Hauts de Seine, France, 92110 收起 <<
NCT00702884	Esophageal Cancer	Phase 2	Completed	-	United States, Ohio ... 展开 >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 <<
NCT00813423	Adult Solid Neoplasm	Phase 1	Active, not recruiting	-	United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 收起 <<
NCT02919371	Renal Cell Carcinoma	Phase 1 Phase 2	Recruiting	December 2021	Saudi Arabia ... 展开 >> Oncology Centre, King Faisal Specialist Hospital and Research Centre Recruiting Riyadh, Saudi Arabia, 11211 Contact: Shouki Bazarbashi, MD 00966 11 442 3935 bazarbashi@kfshrc.edu.sa Contact: Fazal Hussain, MD 966-11-4423949 fhussain@kfshrc.edu.sa 收起 <<
NCT01824615	Ovarian Cancer ... 展开 >> Adverse Effects 收起 <<	Phase 2	Completed	-	Taiwan ... 展开 >> Cathay General Hospital Taipei, Taiwan, 106 收起 <<
NCT00616109	Extensive-Stage Small Cell Lun... 展开 >>g Cancer 收起 <<	Phase 2	Completed	-	United States, Michigan ... 展开 >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 收起 <<
NCT00702884	-		Completed	-	-
NCT00793871	Gastrointestinal Neoplasms, Ga... 展开 >>strointestinal Stromal Tumors 收起 <<	Phase 4	Completed	-	China, Jiangsu ... 展开 >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 收起 <<
NCT00793871	-		Completed	-	-
NCT00459979	Kidney Cancer	Phase 2	Completed	-	United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 <<
NCT00459979	-		Completed	-	-
NCT00910039	Cognitive/Functional Effects ... 展开 >> Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific 收起 <<	Phase 2	Terminated(Slow Accrual)	-	United States, Michigan ... 展开 >> Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Ohio Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 <<
NCT01827254	-		Completed	-	-
NCT03463460	Thymic Carcinoma	Phase 2	Suspended(pending amendment)	July 30, 2020	United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 <<
NCT00890747	Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis Adult Langerhans Cell Histiocytosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Aggressive NK-cell Leukemia AIDS-related Diffuse Large Cell Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Malignancies AIDS-related Small Noncleaved Cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Chronic Phase Chronic Myelogenous Leukemia Clear Cell Renal Cell Carcinoma Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Essential Thrombocythemia Extramedullary Plasmacytoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma HIV Infection HIV-associated Hodgkin Lymphoma Intraocular Lymphoma Isolated Plasmacytoma of Bone Light Chain Deposition Disease Mast Cell Leukemia Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid/NK-cell Acute Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Osteolytic Lesions of Multiple Myeloma Peripheral T-cell Lymphoma Plasma Cell Neoplasm Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Primary Systemic Amyloidosis Progressive Hairy Cell Leukemia, Initial Treatment Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Renal Cell Cancer Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Stage IV Renal Cell Cancer T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenström Macroglobulinemia 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 United States, District of Columbia Lombardi Comprehensive Cancer Center at Georgetown University Washington, District of Columbia, United States, 20057 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States, 20850 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Washington University - Jewish Saint Loius, Missouri, United States, 63110 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 收起 <<
NCT00397787	Acinar Cell Adenocarcinoma of ... 展开 >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer 收起 <<	Phase 2	Completed	-	United States, Illinois ... 展开 >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT00389974	Cervical Adenocarcinoma ... 展开 >> Cervical Adenosquamous Cell Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Cancer Stage IVB Cervical Cancer 收起 <<	Phase 2	Completed	-	Canada, Ontario ... 展开 >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 收起 <<
NCT00910039	-		Terminated(Slow Accrual)	-	-
NCT00389974	-		Completed	-	-
NCT00599313	Metastatic Prostate Cancer	Phase 2	Completed	-	-
NCT01827254	-		Completed	-	France ... 展开 >> CHU de la Timone Marseille, Cedex 5, France, 13335 Hopital albert Michalon Grenoble, Cedex 9, France, 38043 Centre Paul Papin Angers, France, 49100 Hôpital Saint-André Bordeaux Cedex, France, 33075 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre Oscar Lambret - Cancérologie Urologie Digestive Lille Cedex, France, 59020 clinique de la Louvière Lille Cedex, France, 59042 Hopital Dupuytren - Oncologie Medicale Limoges Cedex, France, 87042 Centre Leon Berard, Service d'Oncologie Medicale Lyon Cedex 08, France, 69373 Institut Paoli-Calmettes / Hôpital de jour Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Marseille Cedex, France, 13385 Hopital Europeen Georges Pompidou Paris Cedex 15, France, 75908 Centre Eugene Marquis Rennes, France, 35042 CHU Charles Nicolle ROUEN Cedex, France, 76031 Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire Saint Priest en Jarez Cedex, France, 42271 Centre Rene Gauducheau - Service Oncologie Medicale St Herblain Cedex, France, 44805 Institut Claudius Regaud Toulouse, France, 31000 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 收起 <<
NCT00361309	Hepatocellular Carcinoma ... 展开 >> Liver Cancer 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT00599313	-		Completed	-	-
NCT00519896	Recurrent Thyroid Cancer ... 展开 >> Stage IVA Follicular Thyroid Cancer Stage IVA Papillary Thyroid Cancer Stage IVB Follicular Thyroid Cancer Stage IVB Papillary Thyroid Cancer Stage IVC Follicular Thyroid Cancer Stage IVC Papillary Thyroid Cancer Thyroid Gland Medullary Carcinoma 收起 <<	Phase 2	Completed	-	United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 <<
NCT00444314	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Completed	-	United States, Indiana ... 展开 >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21205 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 收起 <<
NCT00434109	Neuroendocrine Tumor ... 展开 >> Islet Cell Tumor 收起 <<	Phase 2	Completed	-	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 <<
NCT00457743	-		Completed	-	-
NCT00434109	-		Completed	-	-
NCT00457743	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 1 Phase 2	Completed	-	Japan ... 展开 >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Suita, Osaka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan 收起 <<
NCT00715442	Renal Cell Carcinoma	Phase 2	Active, not recruiting	June 2020	United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00519896	-		Completed	-	-
NCT01718327	Unresectable and Advanced Chol... 展开 >>angiocarcinoma 收起 <<	Phase 2	Completed	-	France ... 展开 >> Hôpital Beaujon Clichy, France, 92118 Hôpital privé Jean Mermoz Lyon, France, 69008 CHU La Timone Marseille, France, 13005 Hôpital Saint Antoine Paris, France, 75012 Institut Mutualiste Montsouris Paris, France, 75014 Institut Gustave Roussy Villejuif, France, 94805 收起 <<
NCT01498835	Soft Tissue Sarcoma	Phase 1	Completed	-	Germany ... 展开 >> Helios Klinikum Bad Saarow Bad Saarow, Germany, 15526 University Medical Center Mannheim Mannheim, Germany, 68167 收起 <<
NCT01286896	Malignant Solid Tumour	Phase 1	Unknown	December 2011	Netherlands ... 展开 >> The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Recruiting Amsterdam, Netherlands, 1066CX Contact: Neeltje Steeghs Principal Investigator: Neeltje Steeghs, MD, PhD 收起 <<
NCT00979992	-		Active, not recruiting	-	-
NCT00886132	Adenoid Cystic Carcinoma ... 展开 >> Salivary Gland Cancer 收起 <<	Phase 2	Completed	-	Canada, Ontario ... 展开 >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 <<
NCT00478426	Endometrial Adenocarcinoma ... 展开 >> Endometrial Endometrioid Adenocarcinoma Endometrial Serous Adenocarcinoma Recurrent Uterine Corpus Carcinoma Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVB Uterine Corpus Cancer AJCC v7 Uterine Carcinosarcoma Uterine Corpus Carcinosarcoma 收起 <<	Phase 2	Active, not recruiting	-	-
NCT00338884	Carcinoma, Renal Cell	Phase 2	Completed	-	Argentina ... 展开 >> Pfizer Investigational Site Rosario, Santa Fé, Argentina, (2000) Pfizer Investigational Site Buenos Aires, Argentina, 1431 Pfizer Investigational Site Cordoba, Argentina, X5000AAI Australia, South Australia Pfizer Investigational Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Pfizer Investigational Site Clayton, Victoria, Australia, 3168 Pfizer Investigational Site East Bentleigh, Victoria, Australia, 3165 Brazil Pfizer Investigational Site Porto Alegre, RS, Brazil, 90610-000 Pfizer Investigational Site São Paulo, SP, Brazil, 01308-050 Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Mexico Pfizer Investigational Site Guadalajara, Jalisco, Mexico, 44280 Pfizer Investigational Site Monterrey, Nuevo Leon, Mexico, 64460 Taiwan Pfizer Investigational Site Taichung, Taiwan, 407 Pfizer Investigational Site Tainan, Taiwan, 710 Pfizer Investigational Site Taipei, Taiwan, 112 收起 <<
NCT00706706	Carcinoma, Renal Cell	Phase 4	Completed	-	China, Guangdong ... 展开 >> Pfizer Investigational Site Guangzhou, Guangdong, China, 510060 China, Hubei Pfizer Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu Pfizer Investigational Site Nanjing, Jiangsu, China, 210002 China Pfizer Investigational Site Beijing, China, 100021 Pfizer Investigational Site Beijing, China, 100034 Pfizer Investigational Site Beijing, China, 100036 Pfizer Investigational Site Chong qing, China, 400038 Pfizer Investigational Site Shanghai, China, 200032 Pfizer Investigational Site Shanghai, China, 200127 Pfizer Investigational Site Tianjin, China, 300060 Pfizer Investigational Site Xi'an, China, 710032 收起 <<
NCT03140176	-		Recruiting	December 30, 2020	Algeria ... 展开 >> Pierre Et Marie Curie Center Recruiting Algers, Algeria, 16005 CAC Annaba Recruiting Annaba, Algeria Hanene Djedi Recruiting Annaba, Algeria Egypt National Cancer Institute Recruiting Cairo, Egypt, 11796 Demerdash Hospital Recruiting Cairo, Egypt 收起 <<
NCT00979992	Ovarian Clear Cell Adenocarcin... 展开 >>oma Recurrent Ovarian Carcinoma 收起 <<	Phase 2	Active, not recruiting	-	-
NCT00338884	-		Completed	-	-
NCT03109015	Carcinoma, Renal Cell	Phase 2	Recruiting	May 1, 2019	United States, North Carolina ... 展开 >> Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27705 Contact: Julia Rasmussen 919-681-9822 julia.rasmussen@duke.edu Contact: Diane Pinder 919-668-8375 diane.pinder@duke.edu Principal Investigator: Michael Harrison, MD 收起 <<
NCT02398552	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Unknown	March 2017	China, Beijing ... 展开 >> Chinese acadamy of medical science cancer institute & hospital Not yet recruiting Beijing, Beijing, China, 100021 Contact: Changling Li, MD 0086-10-67781331 changllss@yahoo.com.cn Principal Investigator: Changling Li, MD Peking University First Hospital Not yet recruiting Beijing, Beijing, China, 100034 Contact: Zhisong He, MD 0086-10-83572211 wyj7074@sohu.com Principal Investigator: Zhisong He, MD Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Chuanliang Cui, MD 0086-10-88196951 1008ccl@163.com Contact: Jun Guo, MD,PHD 0086-10-88196317 guoj307@126.com Principal Investigator: Jun Guo, MD,PHD China, Guangdong Sun Yat-sen university cancer center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Fangjian Zhou, MD 0086-20-87343088 zhoufj@sysucc.org.cn Principal Investigator: Fangjian Zhou, MD China, Shanghai Cancer Hospital, Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Dingwei Ye, MD 0086-21-64175590 dwye@163.com Principal Investigator: Dingwei Ye, MD China, Tianjin Tianjin medical university cancer institute & hospital Not yet recruiting Tianjin, Tianjin, China, 300060 Contact: Xin Yao, MD 0086-22-23340123 yaoxin1969@yahoo.com.cn Principal Investigator: Xin Yao, MD 收起 <<
NCT00330564	-		Terminated(Slow accrual.)	-	-
NCT00495625	Liver Cancer	Phase 2	Terminated	-	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 <<
NCT01061411	Clear Cell Sarcoma of the Kidn... 展开 >>ey Recurrent Renal Cell Carcinoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Netherlands Academ Zienkenhuis Bij De University Amsterdam, Netherlands, 1007 MB VU University Medical Center Amsterdam, Netherlands, 1081 HV 收起 <<
NCT00330564	Von Hippel-Lindau Syndrome ... 展开 >> Renal Cell Carcinoma Hemangioblastoma 收起 <<	Phase 2	Terminated(Slow accrual.)	-	United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00495625	-		Terminated	-	-
NCT00706706	-		Completed	-	-
NCT00716820	-		Completed	-	-
NCT00873210	-		Completed	-	Slovakia ... 展开 >> Pfizer Investigational Site Banska Bystrica, Slovakia, 975 17 Pfizer Investigational Site Bojnice, Slovakia, 972 01 Pfizer Investigational Site Bratislava, Slovakia, 812 50 Pfizer Investigational Site Bratislava, Slovakia, 833 10 Pfizer Investigational Site Kosice, Slovakia, 043 91 Pfizer Investigational Site Michalovce, Slovakia, 071 01 Pfizer Investigational Site Nitra, Slovakia, 949 01 Pfizer Investigational Site Poprad, Slovakia, 058 01 Pfizer Investigational Site Presov, Slovakia, 081 81 Pfizer Investigational Site Ruzomberok, Slovakia, 034 26 Pfizer Investigational Site Trebisov, Slovakia, 075 01 Pfizer Investigational Site Trencin, Slovakia, 911 71 Pfizer Investigational Site Trnava, Slovakia, 917 75 Pfizer Investigational Site Zilina, Slovakia, 012 07 收起 <<
NCT00716820	-		Completed	-	-
NCT00668811	Papillary Thyroid Cancer ... 展开 >> Follicular Thyroid Cancer Differentiated Thyroid Cancer 收起 <<	Phase 2	Completed	-	United States, District of Col... 展开 >>umbia MedStar Washington Hospital Center Washington, District of Columbia, United States, 20010 收起 <<
NCT00668811	-		Completed	-	-
NCT03592199	Clear Cell Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Recruiting	December 11, 2022	Brazil ... 展开 >> Instituto do Cancer do Estado de São Paulo Recruiting São Paulo, Brazil, 01246000 Contact: David QB Muniz, MD +551138932691 david.muniz@hc.fm.usp.br Contact: Diogo A Bastos, MD +551138932691 diogo.bastos@hc.fm.usp.br Principal Investigator: David QB Muniz, MD Sub-Investigator: Carlos Dzik, MD, PHD Sub-Investigator: Diogo A Bastos, MD Sub-Investigator: Jamile A Silva, MD Sub-Investigator: Pedro HI Velho, MD 收起 <<
NCT00716625	-		Completed	-	-
NCT00606008	Anaplastic Astrocytoma ... 展开 >> Glioblastoma 收起 <<	Phase 2	Completed	-	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 <<
NCT00606008	-		Completed	-	-
NCT00480935	Renal Cell Carcinoma	Phase 2	Terminated(poor recruitment)	-	Canada, Ontario ... 展开 >> University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 <<
NCT00465179	Renal Cell Cancer ... 展开 >> Kidney Cancer 收起 <<	Phase 2	Completed	-	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00465179	-		Completed	-	-
NCT00673816	-		Terminated(Inability to recrui... 展开 >>t and adequate number of participants) 收起 <<	-	-
NCT00400569	-		Completed	-	-
NCT00864721	Non Small Cell Lung Cancer	Phase 2	Completed	-	United States, Florida ... 展开 >> Ocala Oncology Center Ocala, Florida, United States, 34471 Cancer Centers of Florida, P.A. Ocoee, Florida, United States, 34761 United States, Minnesota Minnesota Oncology Hematology, P.A. Minneapolis, Minnesota, United States, 55404 United States, North Carolina Cancer Centers of North Carolina Raleigh, North Carolina, United States, 27607 United States, Oregon Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States, 97401-8122 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology - Arlington South Arlington, Texas, United States, 76014 Texas Oncology, P.A. - Bedford Bedford, Texas, United States, 76022 Methodist Charlton Cancer Ctr. Dallas, Texas, United States, 75237 Texas Cancer Center of Mesquite Mesquite, Texas, United States, 75150 Texas Oncology Cancer Care and Research Center Waco, Texas, United States, 76712 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Yakima Valley Mem Hosp/North Star Lodge Yakima, Washington, United States, 98902 收起 <<
NCT00864721	-		Completed	-	-
NCT00716625	-		Completed	-	-
NCT03066427	Clear Cell Renal Carcinoma	Phase 2	Recruiting	May 31, 2020	Spain ... 展开 >> ICO Duran i Reynals Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Xavier García del Muro, MD garciadelmuro@iconcologia.net Principal Investigator: Xavier García del Muro, MD Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Cristina Suárez, MD +34 932746000 ext 4919 crsuarez@vhebron.net Principal Investigator: Cristina Suárez, MD Hospital Clínic i Provincial de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Oscar Reig, MD 08036 ext 2811 OREIG@clinic.cat Principal Investigator: Oscar Reig, MD Complejo Hospitalario Regional Reina Sofía Recruiting Córdoba, Spain, 14004 Contact: María J Méndez, MD +34 957012408 mjosemv@yahoo.es Principal Investigator: María J Méndez, MD Hospital Ramón Y Cajal Recruiting Madrid, Spain, 28034 Contact: Teresa Alonso, MD +34 913368263 talonso@oncologiahrc.com Principal Investigator: Teresa Alonso, MD Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Daniel Castellano, MD +34 913908339 cdanicas@hotmail.com Principal Investigator: Daniel Castellano, MD 收起 <<
NCT00400569	Liposarcoma L... 展开 >>eiomyosarcoma Fibrosarcoma Malignant Fibrous Histiocytoma 收起 <<	Phase 2	Completed	-	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 <<
NCT01499121	Clear Cell, Metastatic Renal C... 展开 >>ell Carcinoma 收起 <<	Phase 2	Completed	-	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Kingston General Hospital Research Institute Kingston, Ontario, Canada, K7L 2V7 London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Durham Regional Cancer Centre Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Notre-Dame Hospital Montreal, Quebec, Canada, H2W 1T8 收起 <<
NCT00673816	Von Hippel-Lindau Syndrome	Phase 1 Phase 2	Terminated(Inability to recrui... 展开 >>t and adequate number of participants) 收起 <<	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT02713763	Pancreatic Neuroendocrine Tumo... 展开 >>ur Metastatic 收起 <<	Phase 2	Recruiting	July 2019	Spain ... 展开 >> Hospital Universitario Central de Asturias Recruiting Oviedo, Asturias, Spain, 33011 Contact: Paula Jiménez +34 646662756 palucaji@hotmail.com Principal Investigator: Paula Jiménez Hospital Universitario Valle de Hebrón Active, not recruiting Barcelona, Spain, 08035 Hospital Reina Sofía Recruiting Córdoba, Spain, 14004 Contact: Raquel Serrano +34 957011464 rsblanch@hotmail.com Principal Investigator: Raquel Serrano Hospital Universitario Donostia Active, not recruiting Donostia/San Sebastián, Spain, 20014 Hospital Ramón y Cajal Active, not recruiting Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Rocío García Carbonero 34 91 390 83 39 rgcarbonero@gmail.com Principal Investigator: Rocio Garcia Carbonero Hospital General Universitario J.M. Morales Meseguer Active, not recruiting Murcia, Spain, 30008 Complejo Hospitalario Regional Virgen Del Rocío Recruiting Sevilla, Spain, 41013 Contact: Marta Benavent martabenavent.v@gmail.com Principal Investigator: Marta Benavent Instituto Valenciano de Oncología Active, not recruiting Valencia, Spain, 46009 收起 <<
NCT00794950	Urinary Tract Urothelial Carci... 展开 >>noma 收起 <<	Phase 2	Active, not recruiting	December 2018	United States, Maryland ... 展开 >> Mark P. Schoenberg, MD Baltimore, Maryland, United States, 21287-2101 United States, Michigan Alon Weizer, MD Ann Arbor, Michigan, United States, 48109 收起 <<
NCT03449173	Type B3 Thymoma ... 展开 >> Thymic Carcinoma 收起 <<	Phase 2	Recruiting	March 2, 2021	Italy ... 展开 >> National Cancer Institute Recruiting Milan, Italy, 20133 收起 <<
NCT01073644	-		Terminated(The study was prema... 展开 >>turely discontinued due to poor recruitment on 18th April 2013. There were no safety concerns that led to the decision to terminate.) 收起 <<	-	Philippines ... 展开 >> Chong Hua Hospital Cebu City, Philippines Private Clinic Manila, Philippines 收起 <<
NCT00672594	Prostate Cancer ... 展开 >> Prostatectomy 收起 <<	Phase 2	Completed	-	United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson, University of Texas Houston, Texas, United States, 77030 收起 <<
NCT00672594	-		Completed	-	-
NCT02626754	Renal Cell Carcinoma	Phase 2	Terminated(In most sites had d... 展开 >>ifficult to recruitting subjects.) 收起 <<	-	Taiwan ... 展开 >> Kaohsiung Medical University Chung-HO Memorial Hospital Kaohsiung, Taiwan, 80756 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 81362 Taichung Veterans General Hospital Taichung, Taiwan, 40705 National Taiwan University Hospital Taipei, Taiwan, 10002 Taipei Vterans General Hospital Taipei, Taiwan, 11217 Tri-Service General Hospital Taipei, Taiwan, 11490 Chang Gung Memorial Hospital, Linkou Taoyuan City, Taiwan, 333 收起 <<
NCT00912912	Genitourinary Disease	Phase 2	Terminated(Slow Accrual)	-	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00912912	-		Terminated(Slow Accrual)	-	-
NCT02072031	Anlotinib RCC	Phase 2	Unknown	December 2016	China, Beijing ... 展开 >> Peking Union Medical College Hospital Beijing, Beijing, China, 100005 Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 China, Chongqing Chongqing Cancer Hospital Chongqing, Chongqing, China, 404100 China, Gansu Gansu Province Tumor Hospital Lanzhou, Gansu, China, 730050 China, Guangdong Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China, 510000 China, Guangxi Guangxi medical university affiliated tumor hospital Nanning, Guangxi, China, 530021 China, Heilongjiang Harbin medical university affiliated tumor hospital Haerbin, Heilongjiang, China, 150000 China, Jiangsu The 81st Hospital of Chinese PLA Nanjing, Jiangsu, China, 210000 China, Jilin Jilin Cancer Hospital Changchun, Jilin, China, 132000 China, Liaoning China General Hospital of Shenyang Military Region Shenyang, Liaoning, China, 110000 Liaoning Province Tumor Hospital Shenyang, Liaoning, China, 110042 China, Shandong Qilu Hospital，Shandong University Jinan, Shandong, China, 250012 China, Shanghai Cancer Hospital of Fudan University Shanghai, Shanghai, China, 200000 China, Sichuan West China Hospital，Sichuan University Chengdu, Sichuan, China, 610041 China, Tianjin Tianjin Medical University Cancer Hospital Tianjin, Tianjin, China, 300000 收起 <<
NCT02790580	Breast Cancer	Phase 2	Recruiting	November 2020	Singapore ... 展开 >> National University Hospital, Singapore Recruiting Singapore, Singapore, 119228 Contact: Soo Chin Lee (65) 6779 5555 soo_chin_lee@nuhs.edu.sg 收起 <<
NCT01391130	Metastatic Clear Cell Renal Ce... 展开 >>ll Carcinoma 收起 <<	Phase 2	Terminated(Study Terminated du... 展开 >>e to Insufficient Efficacy) 收起 <<	-	-
NCT00943839	Kidney Cancer	Not Applicable	Completed	-	France ... 展开 >> Centre Antoine Lacassagne Nice, France, 06189 收起 <<
NCT00847015	Bladder Cancer ... 展开 >> Urinary Bladder 收起 <<	Phase 2	Completed	-	United States, New Jersey ... 展开 >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States 收起 <<
NCT03456401	Renal Cancer Cell	Phase 2	Terminated(availability of new... 展开 >> and more promising therapeutic agents than expected in the experimentation in question) 收起 <<	-	Italy ... 展开 >> Istituto Tumori Milan, Mi, Italy, 20156 收起 <<
NCT00847015	-		Completed	-	-
NCT00583063	Solid Tumors	Early Phase 1	Completed	-	United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 收起 <<
NCT00859456	Sarcoma, Soft Tissue	Phase 2	Unknown	December 2013	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT00361244	Colorectal Carcinoma	Phase 1 Phase 2	Terminated(Slow Accrual)	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT01019798	Non Small Cell Lung Cancer	Phase 2	Unknown	December 2011	Taiwan ... 展开 >> Section of Hematology, Department of Medicine,Taipei Medical University Hospital Recruiting Taipei, Taiwan, 110 Contact: Cheng-Jeng Tai, M.D. 886-2-27372181 ext 3903 cjtai@tmu.edu.tw Principal Investigator: Cheng-Jeng Tai, M.D. 收起 <<
NCT01616186	Locally Metastatic Malignant N... 展开 >>eoplasm 收起 <<	Phase 2	Withdrawn	April 2016	-
NCT01026337	Renal Cell Carcinoma ... 展开 >> Stage III Renal Cell Cancer Stage IV Renal Cell Cancer 收起 <<	Not Applicable	Active, not recruiting	-	United States, Pennsylvania ... 展开 >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT00482911	Intraocular Melanoma ... 展开 >> Malignant Conjunctival Neoplasm 收起 <<	Phase 2	Terminated(Investigator left t... 展开 >>he institute.) 收起 <<	-	United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 收起 <<
NCT00720941	-		Active, not recruiting	-	-
NCT00720941	Carcinoma, Renal Cell	Phase 3	Active, not recruiting	June 30, 2019	-
NCT00482911	-		Terminated(Investigator left t... 展开 >>he institute.) 收起 <<	-	-
NCT00089648	-		Completed	-	-
NCT00678119	Renal Cell Carcinoma	Phase 2	Completed	-	United States, California ... 展开 >> City of Hope Duarte, California, United States, 91010 UCLA Los Angeles, California, United States, 90095 United States, Colorado The Urology Center of Colorado Denver, Colorado, United States, 80211 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Indiana The Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kansas University of Kansas Hospital Kansas City, Kansas, United States, 66160 United States, Minnesota University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 United States, North Carolina Carolina's Medical Center / Blumenthal Cancer Center Charlotte, North Carolina, United States, 28204 United States, Ohio Barrett Cancer Cincinnati, Ohio, United States, 45267 United States, Texas CORTPA Dallas, Texas, United States, 75230 United States, Virginia Urology of Virginia-Sentara Medical Group Norfolk, Virginia, United States, 23502 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 收起 <<
NCT00662025	Advanced/Metastatic Breast Can... 展开 >>cer 收起 <<	Phase 2	Completed	-	Japan ... 展开 >> Pfizer Investigational Site Anjo-city, Aichi, Japan Pfizer Investigational Site Nagoya, Aichi, Japan Pfizer Investigational Site Okazaki-City, Aichi, Japan Pfizer Investigational Site Toyoake, Aichi, Japan Pfizer Investigational Site Matsuyama-shi, Ehime, Japan Pfizer Investigational Site Kure, Hiroshima, Japan Pfizer Investigational Site Morioka, Iwate, Japan Pfizer Investigational Site Yokohama, Kanagawa, Japan Pfizer Investigational Site Sakai, Osaka, Japan Pfizer Investigational Site Bunkyo-ku, Tokyo, Japan Pfizer Investigational Site Koto-ku, Tokyo, Japan Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Fukuoka, Japan Pfizer Investigational Site Kagoshima, Japan Pfizer Investigational Site Kyoto, Japan Pfizer Investigational Site Niigata, Japan Pfizer Investigational Site Osaka, Japan 收起 <<
NCT00890110	Renal Cell Cancer	Phase 1 Phase 2	Unknown	December 2011	-
NCT00089648	Carcinoma, Renal Cell	Phase 2	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Duarte, California, United States, 91010 Pfizer Investigational Site Pasadena, California, United States, 91105 Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60637-1460 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232-5536 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75246 收起 <<
NCT03249740	Neovascular Age-Related Macula... 展开 >>r Degeneration 收起 <<	Phase 1 Phase 2	Recruiting	March 2020	United States, Arizona ... 展开 >> Retinal Consultants of Arizona Recruiting Gilbert, Arizona, United States, 85296 Contact: Elisa Martinez 602-222-2221 ext 4115 emartinez@retinalconsultantsaz.com United States, California Retina Institute of California Recruiting Arcadia, California, United States, 91007 Contact: Valentina Bozikovic 626-574-0188 vbozikovic@retina2020.com Retina-Vitreous Associates Medical Group Recruiting Beverly Hills, California, United States, 90211 Contact: Janet Kurokouch 310-289-2478 ext 1243 jkurokouchi@laretina.com United States, Florida Retina Macula Specialists of Miami, LLC Withdrawn Miami, Florida, United States, 33126 United States, Indiana Midwest Eye Institute Recruiting Indianapolis, Indiana, United States, 46290 Contact: Cari Novak 317-805-4596 cari.novak@gmail.com United States, New York Ophthalmic Consultants of Long Island Recruiting Lynbrook, New York, United States, 11563 Contact: Isabel Lezcano 516-593-4026 ilezcano@ocli.net United States, Texas Retina Research Institute of Texas Recruiting Abilene, Texas, United States, 79606 Contact: Courtney Wheeler 325-690-4414 Courtney.Wheeler@txicr.clinic Texas Retina Associates Recruiting Arlington, Texas, United States, 76012 Contact: Michelle Curry 682-433-5457 mcurry@texasretina.com Retina Research Center, PLLC Recruiting Austin, Texas, United States, 78705 Contact: Ivana Gunderson 512-279-1251 igunderson@e-retina.net Medical Center Ophthalmology Associates Recruiting San Antonio, Texas, United States, 78240 Contact: Beatrice Guajardo 210-697-2036 ext 2245 bguajardo@mcoaeyecare.com 收起 <<
NCT00662025	-		Completed	-	-
NCT02231749	Advanced Renal Cell Carcinoma ... 展开 >> Metastatic Renal Cell Carcinoma 收起 <<	Phase 3	Active, not recruiting	September 30, 2019	-
NCT01711268	-		Unknown	December 2014	Australia, New South Wales ... 展开 >> Crown Princess Mary Cancer Centre, Westmead Hospital Recruiting Westmead, New South Wales, Australia, 2145 Contact: Howard Gurney, MBBS (Hon), FRACP +61298455200 howard.gurney@sydney.edu.au Principal Investigator: Howard Gurney, MBBS (Hon), FRACP 收起 <<
NCT00443534	Neoplasms	Not Applicable	Completed	-	-
NCT00573404	Gastrointestinal Stromal Tumor	Phase 1	Terminated(slow accrual)	-	United States, Tennessee ... 展开 >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 收起 <<
NCT00443534	-		Completed	-	-
NCT01225848	Urothelial Carcinoma	Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT01784978	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Terminated(Lack of recruitment... 展开 >>) 收起 <<	-	France ... 展开 >> Hopital Bordeaux University Bordeaux, France Greece ALEXANDRA General Hospital of Athens Athens, Greece, 11528 Spain Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital del Mar Barcelona, Spain, 08003 Hospital Universitario 12 de Octubre Madrid, Spain, 28026 Hospital Clínico San Carlos Madrid, Spain, 28040 Clara Campal. Hospital Sanchinarro Madrid, Spain, 28050 Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital General Universitario de Valencia Valencia, Spain 收起 <<
NCT00620347	Lung Cancer	Phase 2	Completed	-	Korea, Republic of ... 展开 >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of, 411-764 收起 <<
NCT00265317	Carcinoma, Non-Small-Cell Lung	Phase 2	Completed	-	-
NCT02231749	-		Active, not recruiting	-	-
NCT01265901	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 3	Completed	-	-
NCT00609622	Colorectal Neoplasms	Phase 2	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00555256	Non-Small Cell Lung Cancer	Phase 1	Completed	-	United States, Missouri ... 展开 >> Washington University School of medicine St. Louis, Missouri, United States, 63110 收起 <<
NCT01829217	Lung Cancer	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 <<
NCT00609622	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT01829217	-		Completed	-	-
NCT00265317	-		Completed	-	-
NCT01033981	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	Panama ... 展开 >> Pfizer Investigational Site Panama City, Panama 收起 <<
NCT00400114	Esophageal Cancer	Phase 2	Completed	-	Canada, Ontario ... 展开 >> The Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 University Health Network (Princess Margaret & Toronto General Hospitals) Toronto, Ontario, Canada, M5G 2C4 收起 <<
NCT01118039	Bladder Cancer ... 展开 >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer 收起 <<	Phase 2	Unknown	-	Spain ... 展开 >> Hospital Del Mar Recruiting Barcelona, Spain, 08003 Contact: Contact Person 34-39-3248-3861 XVillanueva@imas.imim.es Hospital de la Santa Cruz i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Contact Person 34-93-553-7118 jmaroto@santpau.cat Hospital Universitario San Carlos Recruiting Madrid, Spain, 28040 Contact: Contact Person 34-91-330-3000, Ext. 7935 jgonzalezl.hcsc@salud.madrid.org Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Contact Person 34-91-469-2313 cdanicas@hotmail.com 收起 <<
NCT00474994	Adult Malignant Fibrous Histio... 展开 >>cytoma of Bone Desmoid Tumor Endometrial Cancer Ovarian Cancer Sarcoma Small Intestine Cancer 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 <<
NCT02853331	Renal Cell Carcinoma	Phase 3	Active, not recruiting	January 27, 2020	-
NCT00474994	-		Completed	-	-
NCT00887575	Breast Cancer	Phase 1 Phase 2	Completed	-	United States, Florida ... 展开 >> Holy Cross Hospital Ft. Lauderdale, Florida, United States, 33308 Florida Cancer Specialists North Ft. Myers, Florida, United States, 33916 Florida Cancer Specialists South Ft. Myers, Florida, United States, 33916 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 United States, Tennessee Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 收起 <<
NCT00887575	-		Completed	-	-
NCT00524316	Liver Cancer	Phase 2	Terminated(low accrual)	-	United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 <<
NCT00077974	Carcinoma, Renal Cell	Phase 2	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Duarte, California, United States, 91010-3000 Pfizer Investigational Site Pasadena, California, United States, 91105 Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, Michigan Pfizer Investigational Site Ann Arbor, Michigan, United States, 48109 United States, Minnesota Pfizer Investigational Site Rochester, Minnesota, United States, 55905 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 Pfizer Investigational Site New York, New York, United States, 10022 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97213 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 收起 <<
NCT00387920	Central Nervous System Metasta... 展开 >>ses Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Recurrent Childhood Central Nervous System Embryonal Tumor Unspecified Childhood Solid Tumor, Protocol Specific 收起 <<	Phase 1	Completed	-	United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California Childrens Hospital of Orange County Orange, California, United States, 92868-3874 UCSF-Mount Zion San Francisco, California, United States, 94115 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Centre Hospitalier Universitaire Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 收起 <<
NCT00077974	-		Completed	-	-
NCT00373113	Breast Neoplasms	Phase 3	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT02420821	-		Active, not recruiting	-	-
NCT00747305	Kidney Cancer	Phase 1	Terminated(Study terminated ea... 展开 >>rly due to low accrual.) 收起 <<	-	United States, South Carolina ... 展开 >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 收起 <<
NCT02420821	Renal Cell Carcinoma	Phase 3	Active, not recruiting	December 1, 2021	-
NCT01803503	Solid Tumors ... 展开 >>Breast Cancer Non-small Cell Lung Cancer Prostate Cancer Gastric Cancer 收起 <<	Phase 2	Unknown	April 2018	Singapore ... 展开 >> National University Hospital Not yet recruiting Singapore, Singapore, 119074 Contact: Soo Chin Lee, MBBS (65) 6779 5555 soo_chin_lee@nuhs.edu.sg Principal Investigator: Soo Chin Lee, MBBS National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Soo Chin Lee, MBBS +65 6779 5555 soo_chin_lee@nuhs.edu.sg Principal Investigator: Soo Chin Lee, MBBS 收起 <<
NCT00668863	Unresectable or Metastatic Col... 展开 >>orectal Cancer 收起 <<	Phase 2	Completed	-	Japan ... 展开 >> Pfizer Investigational Site Nagoya, Aichi, Japan Pfizer Investigational Site Chiba-shi, Chiba-ken, Japan Pfizer Investigational Site Matsuyama-shi, Ehime, Japan Pfizer Investigational Site Sapporo-shi, Hokkaido, Japan Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Kochi-shi, Kochi, Japan Pfizer Investigational Site Saku, Nagano, Japan Pfizer Investigational Site Osakasayama-shi, Osaka, Japan Pfizer Investigational Site Takatsuki, Osaka, Japan Pfizer Investigational Site Shimotsuke-shi, Tochigi, Japan Pfizer Investigational Site Minoh/Osaka, Japan 收起 <<
NCT00879619	-		Terminated(Terminated due to s... 展开 >>low accrual.) 收起 <<	-	-
NCT00373113	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00524316	-		Terminated(low accrual)	-	-
NCT00668863	-		Completed	-	-
NCT00879619	Prostate Cancer ... 展开 >> Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage I Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer 收起 <<	Phase 1 Phase 2	Terminated(Terminated due to s... 展开 >>low accrual.) 收起 <<	-	United States, California ... 展开 >> Chao Comprehensive Cancer Center Orange, California, United States, 92868 收起 <<
NCT00930033	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 3	Active, not recruiting	February 2020	France ... 展开 >> Hopital Necker Paris, France, 75015 收起 <<
NCT01070186	Renal Cell Carcinoma	Phase 2	Withdrawn(No participants were... 展开 >> enrolled.) 收起 <<	-	-
NCT00372567	Gastrointestinal Stromal Tumor	Phase 3	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	United States, Michigan ... 展开 >> Pfizer Investigational Site Detroit, Michigan, United States, 48201 Pfizer Investigational Site Farmington Hills, Michigan, United States, 48334 United States, Missouri Pfizer Investigational Site Creve Coeur, Missouri, United States, 63141 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 Pfizer Investigational Site St. Peters, Missouri, United States, 63376 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 Germany Pfizer Investigational Site Goettingen, Germany, 37075 Pfizer Investigational Site Hamburg, Germany, 22767 Hong Kong Pfizer Investigational Site Lai Chi Kok, Kowloon, Hong Kong, 0 Pfizer Investigational Site Tuen Mun, New Territories, Hong Kong, 0 Pfizer Investigational Site Hong Kong, Hong Kong, 0 Italy Pfizer Investigational Site Bologna, Italy, 40138 Pfizer Investigational Site Milano, Italy, 20133 Pfizer Investigational Site San Giovanni Rotondo, Italy, 71013 Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 135-710 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Spain Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Valencia, Spain, 46009 United Kingdom Pfizer Investigational Site Glasgow, United Kingdom, G12 0YH Pfizer Investigational Site Leeds, United Kingdom, LS9 7TF Pfizer Investigational Site London, United Kingdom, NW1 2PG Pfizer Investigational Site London, United Kingdom, SW3 6JJ Pfizer Investigational Site London, United Kingdom, W1 Pfizer Investigational Site Manchester, United Kingdom, M20 4BX 收起 <<
NCT00372567	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00496223	Melanoma	Phase 1 Phase 2	Terminated(toxicities required... 展开 >> dose reduction compromising effectiveness and PI left Moffitt) 收起 <<	-	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 <<
NCT00905021	Metastatic Breast Cancer	Phase 1 Phase 2	Terminated(Sponsor withdrew su... 展开 >>pport) 收起 <<	-	United States, Texas ... 展开 >> Baylor College of Medicine, Lester and Sue Smith Breast Center Houston, Texas, United States, 77030 收起 <<
NCT00798889	Solid Tumors	Not Applicable	Completed	-	-
NCT00453895	Adrenocortical Carcinoma	Phase 2	Unknown	June 2011	Germany ... 展开 >> Charite Berlin Berlin, Germany Dept. of Medicine I, University of Wuerzburg Wuerzburg, Germany, 97080 收起 <<
NCT00499135	Adult Solid Neoplasm ... 展开 >> Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer 收起 <<	Phase 1	Completed	-	United States, Wisconsin ... 展开 >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 <<
NCT00824538	Breast Cancer	Phase 2	Terminated(Closed prematurely ... 展开 >>due to emerging data on toxicity and competing trials.) 收起 <<	-	-
NCT00905021	-		Terminated(Sponsor withdrew su... 展开 >>pport) 收起 <<	-	-
NCT00853125	Kidney Cancer	Phase 2	Terminated(Slow accrual)	-	United States, New Jersey ... 展开 >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 收起 <<
NCT00720148	Solid Tumors	Phase 1	Completed	-	United States, Georgia ... 展开 >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 <<
NCT00695292	Small Cell Lung Cancer	Phase 2	Completed	-	United States, Florida ... 展开 >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Florida Hospital Cancer Insitute Orlando, Florida, United States, 32804 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Louisiana Baton Rouge General Medical Center Baton Rouge, Louisiana, United States, 70806 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 收起 <<
NCT00798889	-		Completed	-	-
NCT00524186	Esophageal Cancer ... 展开 >> Gastric Cancer 收起 <<	Phase 1	Terminated(PI left institute)	-	United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 <<
NCT00695292	-		Completed	-	-
NCT01238055	Advanced Gastric Cancer	Phase 2	Completed	-	Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 <<
NCT02555748	Metastatic Renal Cell Cancer	Phase 4	Recruiting	June 2021	France ... 展开 >> CHU DE BORDEAUX - Hôpital Saint-André Recruiting Bordeaux, France, 33035 Contact: Marine GROSS-GOUPIL, MD + 33 (0)5 56 79 58 08 marine.gross-goupil@chu-bordeaux.fr Principal Investigator: Marine GROSS-GOUPIL, MD Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Guilhem ROUBAUD, MD + 33 (0)5 56 33 33 41 g.roubaud@bordeaux.unicancer.fr Principal Investigator: Guilhem ROUBAUD, MD CHU DE LIMOGES - Hôpital Dupuytren Recruiting Limoges, France, 87042 Contact: Sabrina FALKOWSKI, MD + 33 (0)5 55 05 61 00 sabrina.falkowski@chu-limoges.fr Principal Investigator: Sabrina FALKOWSKI, MD Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Helen BOYLE, MD +33 (0)4 78 78 28 28 helen.boyle@lyon.unicancer.fr Principal Investigator: Aude FLECHON, MD Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: Gwénaëlle GRAVIS-MESCAM, MD + 33 (0)4 91 22 36 77 gravisg@ipc.unicancer.fr Principal Investigator: Gwénaëlle GRAVIS-MESCAM, MD Institut Regional Du Cancer Montpellier Recruiting Montpellier, France, 34298 Contact: Diego TOSI, MD + 33 (0)4 67 61 23 04 diego.tosi@icm.unicancer.fr Principal Investigator: Diego TOSI, MD CH RODEZ Recruiting Rodez, France, 12027 Contact: Guillermo REYES ORTEGA, MD 05 65 55 22 10 g.reyes-ortega@ch-rodez.fr Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD + 33 5 31 15 51 03 Chevreau.christine@iuct-oncopole.fr Principal Investigator: Christine CHEVREAU, MD Gustave Roussy Withdrawn Villejuif, France, 94805 收起 <<
NCT01098903	-		Completed	-	Australia, New South Wales ... 展开 >> Westmead Hospital Westmead, New South Wales, Australia, 2145 Netherlands Academic medical center Amsterdam Amsterdam, Netherlands, 1105AZ Erasmus Medical Center, Daniel Den Hoed Cancer Center Rotterdam, Netherlands, 3075EA 收起 <<
NCT00824538	-		Terminated(Closed prematurely ... 展开 >>due to emerging data on toxicity and competing trials.) 收起 <<	-	-
NCT00462982	-		Completed	-	-
NCT00729833	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00462982	Kidney Cancer ... 展开 >> Melanoma (Skin) Metastatic Cancer 收起 <<	Phase 2	Completed	-	United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 <<
NCT00729833	Advanced Cancer ... 展开 >> Advanced Solid Tumors 收起 <<	Phase 1	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	United States, California ... 展开 >> Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 收起 <<
NCT00849186	Kidney Cancer	Not Applicable	Completed	-	United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 <<
NCT00891878	-		Completed	-	-
NCT00891878	Adenocarcinoma of the Gastroes... 展开 >>ophageal Junction Esophageal Cancer 收起 <<	Phase 2	Completed	-	-
NCT00698815	Recurrent Non-Small Cell Lung ... 展开 >>Carcinoma Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 收起 <<	Phase 2	Completed	-	-
NCT00372424	Breast Cancer	Phase 1	Completed	-	Belgium ... 展开 >> Pfizer Investigational Site Bruxelles, Belgium, 1000 Pfizer Investigational Site Bruxelles, Belgium, 1200 Pfizer Investigational Site Charleroi, Belgium, 6000 Pfizer Investigational Site Sint-Niklaas, Belgium, 9100 Pfizer Investigational Site Wilrijk, Belgium, 2610 Italy Pfizer Investigational Site Meldola, FC, Italy, 47014 Pfizer Investigational Site Milano, Italy, 20132 收起 <<
NCT00408252	Recurrent Disease ... 展开 >> Squamous Cell Head and Neck Carcinoma Palliative Treatment 收起 <<	Phase 2	Terminated(Too frequent grade ... 展开 >>3-4 toxicities) 收起 <<	-	Belgium ... 展开 >> Cliniques Universiatires St LUC UCL Bruxelles, Belgium, 1200 clinique Sainte Elisabeth Namur, Belgium, 5000 Clinique universiataire de Mont Godinnes UCL Yvoir, Belgium, 5004 France Centre Jean Perrin Clermont Ferrand, France, 263011 Centre G-f Leclerc DIJON Cedex, France, 8021079 Centre Alexis Vautrin Nancy, France, 4511 René Gauducheau Saint Herblain Cedex, France, 44805 CHU Bretonneau Tours cedex 1, France, 37044 Institut Gustave Roussy Villejuif Cedex, France, 94805 收起 <<
NCT00698815	-		Completed	-	-
NCT01147822	Carcinoma, Renal Cell	Phase 2	Active, not recruiting	September 30, 2019	China, Guangdong ... 展开 >> Novartis Investigative Site Guangzhou, Guangdong, China, 510060 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Beijing, China, 100036 Novartis Investigative Site Beijing, China, 100853 Novartis Investigative Site Beijing, China Novartis Investigative Site Shanghai, China, 200032 Novartis Investigative Site Shanghai, China, 200127 Novartis Investigative Site Tianjin, China, 300060 Korea, Republic of Novartis Investigative Site Daejeon, Korea, Republic of, 301-721 Novartis Investigative Site Goyang-si, Gyeonggi-Do, Korea, Republic of, 410-769 Novartis Investigative Site Seoul, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 135-710 Novartis Investigative Site Seoul, Korea, Republic of, 138-736 Taiwan Novartis Investigative Site Kaohsiung Hsien, Taiwan, 833 Novartis Investigative Site Taichung, Taiwan, 40402 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 11217 Novartis Investigative Site Taoyuan County, Taiwan, 333 收起 <<
NCT00814021	Kidney Cancer ... 展开 >> Metastatic Cancer 收起 <<	Phase 2	Completed	-	France ... 展开 >> Institut Claudius Regaud Toulouse, France, 31052 收起 <<
NCT01147822	-		Active, not recruiting	-	-
NCT01309633	Nasopharyngeal Carcinoma	Phase 2	Unknown	September 2018	Singapore ... 展开 >> National University Hospital Recruiting Kent Ridge, Singapore, 119074 Contact: Boon Cher Goh, MBBS (65) 6772 4140 Boon_Cher_Goh@nuhs.edu.sg Contact: Christine Vergara (65) 6772 4619 christine_vergara@nuhs.edu.sg Sub-Investigator: Boon Cher Goh, MBBS 收起 <<
NCT02404584	-		Recruiting	September 2018	France ... 展开 >> CHRU de Montpellier - Hôpital Saint-Eloi Recruiting Montpellier cedex 5, France, 34295 Principal Investigator: Délphine Topart, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Nadine Houédé, MD, PhD Sub-Investigator: Alexandre Evard, Pharmd, PhD Sub-Investigator: Jean-Christophe Boyer, MD, PhD Institut de Cancérologie du Gard (ICG) Recruiting Nîmes Cedex 9, France, 30029 Principal Investigator: Angélique Chapellie, MD 收起 <<
NCT00393796	Bladder Cancer	Phase 2	Terminated(Low accrual)	-	United States, California ... 展开 >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 <<
NCT00372424	-		Completed	-	-
NCT00578526	Urothelial Cancer ... 展开 >> Bladder Cancer Adult 收起 <<	Phase 2	Completed	-	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Health Sciences Centre London, Ontario, Canada, T6A 4L6 收起 <<
NCT00393796	-		Terminated(Low accrual)	-	-
NCT00254540	Carcinoma, Renal Cell	Phase 2	Completed	-	Japan ... 展开 >> Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Tsukuba, Ibaragi, Japan Pfizer Investigational Site Osakasayama, Osaka, Japan Pfizer Investigational Site Hamamatsu, Shizuoka, Japan Pfizer Investigational Site Sunto-gun, Shizuoka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Pfizer Investigational Site Akita, Japan Pfizer Investigational Site Fukuoka, Japan Pfizer Investigational Site Osaka, Japan Pfizer Investigational Site Tokushima, Japan Pfizer Investigational Site Yamagata, Japan 收起 <<
NCT00694096	Renal Cell Cancer	Phase 1	Completed	-	United States, Utah ... 展开 >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 收起 <<
NCT00291577	Breast Neoplasms	Phase 1	Completed	-	Belgium ... 展开 >> Pfizer Investigational Site Bruxelles, Belgium, 1000 Italy Pfizer Investigational Site Milano, Italy, 20133 Sweden Pfizer Investigational Site Stockholm, Sweden, 171 76 收起 <<
NCT00694096	-		Completed	-	-
NCT00849186	-		Completed	-	-
NCT01934452	-		Recruiting	April 15, 2020	France ... 展开 >> CHU de la Timone Recruiting Marseille, Cedex 5, France, 13335 CHRU HOTEL DIEU - Service Urologie Recruiting Angers Cedex, France, 49933 C.H.U Morvan Recruiting Brest, France, 29000 Clinique Victor Hugo Recruiting Le Mans, France, 72015 Institut Paoli-Calmettes Recruiting Marseille Cedex 09, France, 13273 Institut Paoli-Calmettes / Hôpital de jour Recruiting Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Recruiting Marseille Cedex, France, 13385 CRLC Val d'Aurelle Recruiting Montpellier cedex 05, France, 34295 Hopital Europeen Georges Pompidou Recruiting Paris Cedex 15, France, 75908 Centre Hospitalier Lyon Sud Recruiting Pierre Bénite Cedex, France, 69495 Clinique Chirurgicale de l'Orangerie, Chiliotherapie Recruiting Strasbourg, France, 67010 Centre Alexis Vautrin Recruiting Vandoeuvre les Nancy, France, 54511 Institut Gustave Roussy Active, not recruiting Villejuif Cedex, France, 94805 收起 <<
NCT00291577	-		Completed	-	-
NCT02282059	-		Recruiting	December 12, 2022	China, Anhui ... 展开 >> Oncology Department, The Second Affiliated Hospital of Anhui Medical University Active, not recruiting Hefei, Anhui, China, 230061 China, Beijing Cancer Institute and Hospital, Chinese Academy of Medical Science Not yet recruiting Beijing, Beijing, China, 100021 Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting Beijing, Beijing, China, 100021 China, Guangdong SUN Yat-Sen University Cancer Center Active, not recruiting Guangzhou, Guangdong, China, 510060 China, Heilongjiang The Affiliated Tumour Hospital of Harbin Medical University Recruiting Haerbin, Heilongjiang, China, 150081 China, Henan The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 China, Jiangsu Nanjing Bayi Hospital Active, not recruiting Nanjing, Jiangsu, China, 210002 Nanjing General Hospital of Nanjing Military Command/Hepatobiliary Surgery Department Active, not recruiting Nanjing, Jiangsu, China, 210002 Jiangsu Cancer Hospital Active, not recruiting Nanjing, Jiangsu, China, 210009 Jiangsu Province Hospital Active, not recruiting Nanjing, Jiangsu, China, 210029 China, Shannxi Digestive surgery Department, The First Affiliated Hospital, The Fourth Military Medical University Recruiting Xi'an, Shannxi, China, 710032 China, Sichuan West China Hospital of Sichuan University/Hepatobiliary Pancreatic Surgery Recruiting Chengdu, Sichuan, China, 610041 China, Tianjin Tianjin Cancer Hospital Active, not recruiting Tianjin, Tianjin, China, 300060 China, Zhejiang Zhejiang Cancer Hospital, Oncology department Active, not recruiting Hangzhou, Zhejiang, China, 310022 China The PLA of 307 Hospital Active, not recruiting Beijing, China, 100071 Fudan University Shanghai Cancer Center Active, not recruiting Shanghai, China, 200032 Tianjin Medical University General Hospital/General Surgery Active, not recruiting Tianjin, China, 300052 收起 <<
NCT00712504	Advanced Solid Tumors ... 展开 >> Non Small Cell Lung Cancer 收起 <<	Phase 1	Completed	-	United States, Alabama ... 展开 >> Pfizer Investigational Site Birmingham, Alabama, United States, 35233-2115 Pfizer Investigational Site Birmingham, Alabama, United States, 35233 Pfizer Investigational Site Birmingham, Alabama, United States, 35294 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 收起 <<
NCT01441661	-		Completed	-	China, Beijing ... 展开 >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 China, Hubei Tongji Hospital, Tongji Medical College of Hust Wuhan, Hubei, China, 430030 收起 <<
NCT01121562	Pancreatic Neuroendocrine Tumo... 展开 >>rs 收起 <<	Phase 2	Completed	-	Japan ... 展开 >> Aichi Cancer Center Central Hospital Nagoya, Aichi, Japan National Cancer Center Hospital Chuo-ku, Tokyo, Japan Kyushu University Hospital Fukuoka, Japan Osaka Police Hospital Osaka, Japan 收起 <<
NCT00254540	-		Completed	-	-
NCT00398112	-		Completed	-	-
NCT01164202	Liver Cancer	Phase 2 Phase 3	Completed	-	France ... 展开 >> CHU Nord Amiens, France CHR Annecy, France Institut Sainte Catherine Avignon, France CHU J Minjoz Besancon, France Institut Bergonié Bordeaux, France CH Béziers, France CHU Côte de Nacre Caen, France CHU Clermont Ferrand, France Clinique des Cèdres Cornebarrieu, France CHU Bocage Dijon, France CH Guilherand Granges, France Hôpital Claude Huriez Lille, France, 59037 Hopital Dupuytren Limoges, France CHBS Lorient, France Hôpital Privé Jean Mermoz Lyon, France CH Ambroise Paré Marseille, France CH Conception Marseille, France CHU La Timone Marseille, France Hôpital Saint Joseph Marseille, France CHRU Saint Eloi Montpellier, France CHU -Hôpital de l'Archet II Nice, France CHR Orléans, France Hopital Tenon Paris, France, 75970 Groupe Hospitalier Paris St Joseph Paris, France Hôpital Européen Georges Pompidou Paris, France CHU Jean Bernard Poitiers, France CHU Robert Debré Reims, France CAC Rennes, France CHU Rouen, France CHU Tours, France Institut Gustave Roussy Villejuif, France 收起 <<
NCT00906360	Metastatic Squamous Neck Cance... 展开 >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage III Salivary Gland Cancer Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage III Verrucous Carcinoma of the Larynx Stage III Verrucous Carcinoma of the Oral Cavity Stage IV Salivary Gland Cancer Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IV Verrucous Carcinoma of the Larynx Stage IV Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary 收起 <<	Phase 1	Terminated	-	United States, Illinois ... 展开 >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Loyola University Medical Center Maywood, Illinois, United States, 60153 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 60702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc - State Boulevard Fort Wayne, Indiana, United States, 46845 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 United States, Michigan University of Michigan University Hospital Ann Arbor, Michigan, United States, 48109 United States, Missouri Saint John's Mercy Medical Center Saint Louis, Missouri, United States, 63141 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 <<
NCT00398112	B-cell Chronic Lymphocytic Leu... 展开 >>kemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia 收起 <<	Phase 2	Completed	-	United States, Minnesota ... 展开 >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 收起 <<
NCT00511849	Neoplasms	Phase 1	Completed	-	United States, Michigan ... 展开 >> Pfizer Investigational Site Detroit, Michigan, United States, 48201 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 收起 <<
NCT01121562	-		Completed	-	-
NCT01215565	Hepatocellular Carcinoma ... 展开 >> Fibrolamellar Hepatocellular Carcinoma 收起 <<	Phase 2	Terminated(lack of inclusion)	-	France ... 展开 >> Hôpital Beaujon Clichy, Hauts de Seine, France, 92110 收起 <<
NCT01402089	Non Small-cell Lung Cancer ... 展开 >> Renal-cell Cancer Gastrointestinal Stroma Tumor 收起 <<	Phase 4	Completed	-	Switzerland ... 展开 >> Cantonal Hospital St.Gallen St.Gallen, Switzerland, 9007 收起 <<
NCT00903175	-		Completed	-	-
NCT01210053	Non-small Cell Lung Cancer	Phase 2	Unknown	March 2012	China, Chongqing ... 展开 >> Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: yang zhenzhou, doctor yangzhenzhou@sohu.com 收起 <<
NCT00903175	Renal Cell Carcinoma	Phase 2	Completed	-	-
NCT00421512	Metastatic Renal Cell Carcinom... 展开 >>a Kidney Cancer 收起 <<	Phase 1	Completed	-	United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10021 收起 <<
NCT01850147	Cancer Lung C... 展开 >>ancer 收起 <<	Phase 2	Unknown	December 2014	China ... 展开 >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 收起 <<
NCT01673386	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Completed	-	-
NCT01070706	Breast Cancer	Phase 1 Phase 2	Completed	-	Korea, Republic of ... 展开 >> Center for breast cancer, National Cancer Center Goyang, Kyeonggido, Korea, Republic of, 410-769 收起 <<
NCT01185366	Kidney Cancer	Phase 2	Active, not recruiting	August 2019	United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute/Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute - University of Utah Salt Lake City, Utah, United States, 84112 收起 <<
NCT00806663	Metastatic Colorectal Cancer ... 展开 >> Liver Metastases 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> Innere Univ.-Klinik u. Poliklinik Tumorforschung Essen, Germany, D-45122 Klinik für Tumorbiologie Freiburg, Germany, D-79106 Medizinische Universitätsklinik der Albert-Ludwigs-Universität Freiburg Freiburg, Germany, D-79106 Marienhospital Herne, Germany, D-44625 收起 <<
NCT03641326	Gliosarcoma C... 展开 >>entral Nervous System Sarcoma 收起 <<	Phase 2	Not yet recruiting	September 30, 2020	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Not yet recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 <<
NCT01164228	Kidney Cancer	Phase 2	Active, not recruiting	May 31, 2023	-
NCT02761057	Stage III Renal Cell Cancer AJ... 展开 >>CC v7 Stage IV Renal Cell Cancer AJCC v7 Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Unresectable Renal Cell Carcinoma 收起 <<	Phase 2	Suspended(Scheduled Interim Mo... 展开 >>nitoring) 收起 <<	-	-
NCT00617253	Cancer Renal ... 展开 >>Cell Carcinoma 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> Novo Nordisk Investigational Site Frankfurt, Germany, 60488 Novo Nordisk Investigational Site Hamburg, Germany, 20246 Novo Nordisk Investigational Site Hannover, Germany, 30625 Netherlands Novo Nordisk Investigational Site Amsterdam, Netherlands, 1066 CX Novo Nordisk Investigational Site Nijmegen, Netherlands, 6525 GA 收起 <<
NCT01829841	Renal Cell Cancer ... 展开 >> Metastatic Renal Cell Cancer 收起 <<	Phase 2	Completed	-	China ... 展开 >> Cancer Institute and Hospital Chinese Academy of Medical Sciences Beijing, China, 100021 收起 <<
NCT01907607	Advanced Gastrointestinal Stro... 展开 >>mal Tumors 收起 <<	Phase 2	Active, not recruiting	April 2019	France ... 展开 >> Institut Bergonié Bordeaux, Gironde, France, 33076 Centre Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69373 Hôpital de la Timone - AP-HM Marseille, France, 13385 Centre René Gauducheau Nantes, France, 44805 Hôpital Saint-Antoine (AP-HP) Paris, France, 75571 CHU de REIMS - Hôpital Robert Debré Reims, France, 51092 Institut Gustave Roussy Villejuif, France, 94800 收起 <<
NCT00570635	Gastrointestinal Stromal Tumor... 展开 >>s Gastrointestinal Neoplasms 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> Los Angeles, California, United States, 90095 United States, Illinois Park Ridge, Illinois, United States, 60068 United States, Massachusetts Boston, Massachusetts, United States, 02115 收起 <<
NCT00489944	Intraocular Melanoma	Phase 2	Unknown	-	United States, California ... 展开 >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD 760-452-3340 emcclay@pacificoncology.com 收起 <<
NCT00979329	-		Completed	-	Netherlands ... 展开 >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH 收起 <<
NCT00930345	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 4	Terminated	-	France ... 展开 >> HEGP Paris, France, 75015 收起 <<
NCT00471328	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 3	Completed	-	-
NCT00471328	-		Completed	-	-
NCT00491738	Renal Cell Carcinoma	Phase 2	Terminated(Based on the data c... 展开 >>ollected, the combination of bevacizumab and sunitinib appeared to be poorly tolerated.) 收起 <<	-	-
NCT01216371	Renal Cell Carcinoma ... 展开 >> Pulmonary Metastases 收起 <<	Phase 2	Unknown	October 2015	Germany ... 展开 >> Universitätsmedizin Charité Berlin Not yet recruiting Berlin, Germany, 10117 Contact: Steffen Weikert, Priv. Doz. Dr. med. 030/84 45-40 84 Principal Investigator: Steffen Weikert, Priv. Doz. Dr. med. Sub-Investigator: Kempkensteffen Carsten, Dr. med. Sub-Investigator: Jonas Busch, Dr. med. Sub-Investigator: Jan Gregor, Dr. med. Sub-Investigator: Jens Neudecker, Dr. med. Sub-Investigator: Jens C. Rückert, Dr. med. Sub-Investigator: Gertrud Feldmann Franziskus Krankenhaus Not yet recruiting Berlin, Germany, 10787 Contact: Jörg Neymeyer, Dr. med. 030/26 38-38 01 Principal Investigator: Jörg Neymeyer, Dr. med. Sub-Investigator: Thomas Wülfing, Dr. med. Helios Klinikum Emil von Behring Not yet recruiting Berlin, Germany, 14165 Contact: Kollmeier Jens, Dr. med. 030/81 02-14 47 Sub-Investigator: Jens Kollmeier, Dr. med. Sub-Investigator: Bettina Schlolaut, Dr. med. university hospital of Düsseldorf Recruiting Düsseldorf, Germany, 40255 Contact: Peter Albers, Prof. Dr. med. 0211/811-81 10 Principal Investigator: Peter Albers, Prof. Dr. med. Sub-Investigator: Jasper Decoene Sub-Investigator: Zenginli Hakan Sub-Investigator: Claus F. Eisenberger, Prof. Dr. med. Sub-Investigator: Wolfram T. Knoefel, Prof. Dr. med. Sub-Investigator: Almut Diem university hospital of Essen Recruiting Essen, Germany, 45122 Contact: Herbert Rübben, Prof. Dr. med. 0201/723-32 10 Principal Investigator: Herbert Rübben, Prof. Dr. med. Sub-Investigator: Marcus Schenk, Dr. med. Sub-Investigator: Farnk vom Dorp, Dr. med. Sub-Investigator: Min Ju, Dr. med. Sub-Investigator: Stephan Tschirdewahn Sub-Investigator: Michaela Löbert Ruhrlandklinik Department of Thoracic Surgery Not yet recruiting Essen, Germany, 45239 Contact: Christiane Zimmermann 0201/433-43 24 Sub-Investigator: Georgios Stamatis, Prof. Dr. med. Sub-Investigator: Stefan Welter, Dr. med. Sub-Investigator: Silvia Fechner, Dipl. med. university hospital of Freiburg Recruiting Freiburg, Germany, 79106 Contact: Ulrich Wetterauer, Prof. Dr. med. 0761/270-2891 Principal Investigator: Ulrich Wetterauer, Prof. Dr. med. Sub-Investigator: Christian Leiber, Dr. med. Sub-Investigator: Christian Stremmel, Prof. Dr. med. Sub-Investigator: Jutta Günter, Dr. med. university Hospital of Heidelberg Recruiting Heidelberg, Germany, 69119 Contact: Markus Hohenfellner, Prof. Dr. med. 06221/56-63 21 Principal Investigator: Markus Hohenfellner, Prof. Dr. med. Sub-Investigator: Pahernick Sascha, Priv. Doz. Dr. med. Sub-Investigator: Gencay Hatiboglu, Dr. med. Sub-Investigator: Johannes Huber, Dr. Dr. med. Sub-Investigator: Joachim Pfannschmidt, Priv. Doz. Dr. med. Sub-Investigator: Hendrik Dienemann, Prof. Dr. med. urological hospital of Maria Hilf Krankenhaus Krefeld Recruiting Krefeld, Germany, 47805 Contact: Susanne Krege, Priv. Doz. Dr. med. 02151/334-52 74 Principal Investigator: Susanne Krege, Priv. Doz. Dr. med. Sub-Investigator: Florian Hartmann, Dr. med. Hospital of Großhadern Not yet recruiting München, Germany, 81377 Contact: Michael Staehler, Dr. med. 089/70 95-0 Principal Investigator: Michael Staehler, Dr. med. Sub-Investigator: Cordula Nordhaus, Dr. med. Sub-Investigator: Philipp Nuhn, Dr. med. Sub-Investigator: Hauke Winter, Priv. Doz. Dr. med. Sub-Investigator: Rudolf Hatz, Prof. Dr. med. Sub-Investigator: Sylvia Dondl Dr.-Horst-Schmidt-Kliniken GmbH Recruiting Wiesbaden, Germany, 65199 Contact: Norbert Frickhofen, Prof. Dr. med. 0611/43-30 09 Principal Investigator: Norbert Frickhofen, Prof. Dr. med. Sub-Investigator: Bernd Jung, Dr. med. Sub-Investigator: Heinz G. Fuhr, Dr. med. Sub-Investigator: Joachim Schirren, Prof. Dr. med. Sub-Investigator: Servet Bölükbas, Dr. med. Sub-Investigator: Sabine Labenz Sub-Investigator: Birgit Wilde Sub-Investigator: Klaudia Fischbach 收起 <<
NCT00532064	-		Terminated(Terminated per PI's... 展开 >> request) 收起 <<	-	United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00075218	Gastrointestinal Stromal Tumor	Phase 3	Completed	-	-
NCT00457392	Carcinoma, Non-Small Cell Lung	Phase 3	Completed	-	-
NCT00075218	-		Completed	-	-
NCT00434356	Metastatic Breast Cancer	Phase 2	Terminated(Based on data colle... 展开 >>cted, the combination appeared to be poorly tolearated.) 收起 <<	-	-
NCT00491738	-		Terminated(Based on the data c... 展开 >>ollected, the combination of bevacizumab and sunitinib appeared to be poorly tolerated.) 收起 <<	-	-
NCT00626509	Kidney Cancer	Phase 2	Unknown	-	Italy ... 展开 >> Ospedale Sacro Cuore Recruiting Negrar, Italy, 37024 Contact: Contact Person 39-045-601-3912 收起 <<
NCT00434356	-		Terminated(Based on data colle... 展开 >>cted, the combination appeared to be poorly tolearated.) 收起 <<	-	-
NCT00457392	-		Completed	-	-
NCT00709995	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Active, not recruiting	December 2018	Austria ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vienna, Austria, A1090 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif, France, 94805 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00149 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 00909 收起 <<
NCT03519542	-		Active, not recruiting	June 2018	Spain ... 展开 >> Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, A Coruña, Spain, 15706 Hospital Universitario central de Asturias Oviedo, Asturias, Spain, 33011 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Universitarios de Burgos Burgos, Spain, 09006 Hospital Universiario de León León, Spain, 24080 Hospital Gregorio Marañón Madrid, Spain, 28007 Hospital Universitario Ramón y Cajal Madrid, Spain, 28024 Hospital Clínico (Madrid) Madrid, Spain, 28040 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain Hospital Universitario Carlos Haya Málaga, Spain, 29010 Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 收起 <<
NCT01246843	-		Completed	-	Netherlands ... 展开 >> University Medical Centre Nijmegen Nijmegen, Gelderland, Netherlands, 6500 HB 收起 <<
NCT02428335	-		Unknown	June 2017	Canada, Alberta ... 展开 >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 收起 <<
NCT00537056	Kidney Neoplasms ... 展开 >> Carcinoma, Renal Cell Kidney (Renal Cell) Cancer 收起 <<	Not Applicable	Completed	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT00732914	Renal Cell Carcinoma	Phase 3	Completed	-	Germany ... 展开 >> Urologische Klinik Mannheim, Baden-Wuerttemberg, Germany, 68167 收起 <<
NCT01014065	-		Completed	-	Canada, Alberta ... 展开 >> University of Alberta/ Cross Cancer Institute Edmonton, Alberta, Canada 收起 <<
NCT00077987	Colorectal Neoplasms	Phase 2	Completed	-	-
NCT01122888	Adult Giant Cell Glioblastoma ... 展开 >> Adult Glioblastoma Adult Gliosarcoma Adult Solid Neoplasm Recurrent Adult Brain Neoplasm 收起 <<	Phase 1	Terminated	-	United States, Illinois ... 展开 >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 收起 <<
NCT03013946	Renal Cell Carcinoma, Metastat... 展开 >>ic Renal Cell Cancer, Recurrent 收起 <<	Phase 3	Recruiting	May 2020	Germany ... 展开 >> Medizinische Hochschule Hannover Not yet recruiting Hannover, Germany, 30625 Contact: Viktor Grünwald, Dr. +49 511 532 ext 2301 gruenwald.viktor@mh-hannover.de Zentrum für Onkologie und Urologie Rostock Recruiting Rostock, Germany, 18107 Contact: Andreas Hübner, Dr. 收起 <<
NCT00915993	Kidney Cancer	Not Applicable	Unknown	-	United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers 800-474-9892 收起 <<
NCT00553696	Stomach Neoplasms	Phase 1	Completed	-	Japan ... 展开 >> Aichi cancer center central hospital / Medical Oncology Nagoya, Aichi, Japan, 464-8681 Saku Central Hospital, GI Devision Saku, Nagano, Japan Shizuoka Cancer Center Suntougun, Shizuoka, Japan, 411-8777 收起 <<
NCT02184416	-		Recruiting	July 20, 2019	-
NCT00553696	-		Completed	-	-
NCT00226811	-		Completed	-	-
NCT03075423	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Recruiting	December 31, 2022	Germany ... 展开 >> Medizinische Hochschule Hannover Recruiting Hannover, Niedersachsen, Germany, 30625 Charité Universitätsmedizin Berlin Recruiting Berlin, Germany University Hospital Erlangen Recruiting Erlangen, Germany, 91054 Contact: Stefan Krause, Prof. Universitätsklinikum Essen Recruiting Essen, Germany Goethe University Frankfurt Recruiting Frankfurt am Main, Germany, D-60590 Contact: Lothar Prof. Dr. med. Bergmann, MD +40 69 63015121 l.bergmann@em.uni-frankfurt.de Contact: Nicola Goekbuget, MD Uiversitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany Uniklinikum Recruiting Jena, Germany Universitätsklinkum Gießen und Marburg Recruiting Marburg, Germany Klinikum Rechts der Isar der TU München Recruiting München, Germany University of Muenster Recruiting Münster, Germany, 48149 Universitätsklinik Tübingen Recruiting Tübingen, Germany Medizinische Universitätsklinik Ulm Recruiting Ulm, Germany, 89070 收起 <<
NCT00078000	Breast Neoplasms	Phase 2	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Greenbrae, California, United States, 94904 Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Colorado Pfizer Investigational Site Aurora, Colorado, United States, 80010 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60612-3824 United States, Indiana Pfizer Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland Pfizer Investigational Site Baltimore, Maryland, United States, 21231 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 收起 <<
NCT00434226	Non-Small Cell Lung Cancer	Phase 2	Terminated(Based on data colle... 展开 >>cted, the combination appeared to be poorly tolearated.) 收起 <<	-	-
NCT00434226	-		Terminated(Based on data colle... 展开 >>cted, the combination appeared to be poorly tolearated.) 收起 <<	-	-
NCT00226811	Stomach Neoplasms	Phase 2	Completed	-	China, Jiangsu ... 展开 >> Pfizer Investigational Site Nanjing, Jiangsu, China, 210002 China Pfizer Investigational Site Beijing, China, 100036 Pfizer Investigational Site Beijing, China Pfizer Investigational Site Guangzhou, China, 510515 Hong Kong Pfizer Investigational Site Hong Kong, Hong Kong Pfizer Investigational Site Shatin, Hong Kong Italy Pfizer Investigational Site Ancona, Italy, 60020 Pfizer Investigational Site Genova, Italy, 16132 Japan Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Suntougun, Shizuoka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Pfizer Investigational Site Seoul, Korea, Republic of, 135-710 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Portugal Pfizer Investigational Site Porto, Portugal, 4200-072 Taiwan Pfizer Investigational Site Kwei-Shan, Taoyuan, Taiwan, 333 Pfizer Investigational Site Taipei, Taiwan, 100 收起 <<
NCT00836745	-		Completed	-	India ... 展开 >> Pfizer Investigational Site New Delhi, Delhi, India, 110 085 Pfizer Investigational Site Bangalore, Karnataka, India, 560 027 Pfizer Investigational Site Mumbai, Maharashtra, India, 400014 Pfizer Investigational Site Chandigard, Punjab, India, 141402 Pfizer Investigational Site Kolkata, West Bengal, India, 700 106 Pfizer Investigational Site Delhi, India, 110 060 Pfizer Investigational Site Jaipur, India, 302006 收起 <<
NCT00836745	-		Completed	-	-
NCT00137449	-		Completed	-	-
NCT00137449	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Pfizer Investigational Site Boston, Massachusetts, United States, 02115 France Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Milano, Italy, 20133 收起 <<
NCT02315625	Neuroendocrine Tumors ... 展开 >> Neuroendocrine Carcinoma Neuroendocrine Neoplasms Carcinoma, Neuroendocrine Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas 收起 <<	Phase 2	Recruiting	December 31, 2025	United States, Illinois ... 展开 >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Xavier Keutgen, MD 312-563-1557 xavier_keutgen@rush.edu United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 <<
NCT00718562	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Completed	-	Japan ... 展开 >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Niigata-city, Niigata, Japan, 951-8520 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 收起 <<
NCT00537056	-		Completed	-	-
NCT00435409	Breast Neoplasms	Phase 3	Completed	-	-
NCT01396408	Advanced Rare Tumours	Phase 2	Active, not recruiting	December 2018	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Izaak Walton Killam (IWK) Health Centre Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 CHU Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 收起 <<
NCT03424876	-		Recruiting	August 8, 2018	China, Beijing ... 展开 >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jian Li, MD 收起 <<
NCT02811861	Renal Cell Carcinoma	Phase 3	Recruiting	February 2021	-
NCT00923117	-		Terminated(The study was termi... 展开 >>nated based on results of an interim analysis for futility.) 收起 <<	-	-
NCT00435409	-		Completed	-	-
NCT00923117	Glioblastoma Multiforme ... 展开 >> Malignant Gliomas Anaplastic Gliomas 收起 <<	Phase 2	Terminated(The study was termi... 展开 >>nated based on results of an interim analysis for futility.) 收起 <<	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT01506336	Gastro Intestinal Stromal Tumo... 展开 >>r 收起 <<	Phase 2	Completed	-	France ... 展开 >> Institute Gustave Roussy (IGR) Villejuif, France, 94815 收起 <<
NCT00417677	Renal Cell Carcinoma	Phase 1 Phase 2	Terminated(Decision was made n... 展开 >>ot to attempt a lower dose) 收起 <<	-	United States, Maryland ... 展开 >> Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston, Massachusetts, United States, 02215 United States, New York New York, New York, United States, 10021 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111 收起 <<
NCT00790595	Prostate Cancer	Phase 1	Completed	-	United States, California ... 展开 >> University of California, Los Angeles, Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 收起 <<
NCT00979966	Non-clear Cell Renal Cell Canc... 展开 >>er 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> Charité - Campus Virchow Klinikum Berlin, Germany Charité - Mitte Berlin, Germany Vivantes Klinikum am Urban Berlin, Germany Evangelische Kliniken Bonn gGmbH - Johanniter-Krankenhaus Bonn, Germany Universitätsklinikum Düsseldorf Düsseldorf, Germany Universitätsklinikum Essen Essen, Germany Klinikum der J.W. Goethe Universität Frankfurt, Germany Martin-Luther-Universität Halle-Wittenberg Halle, Germany Universitätskrankenhaus Jena Jena, Germany UK-SH Campus Lübeck Lübeck, Germany Klinikum Oldenburg gGmbH Oldenburg, Germany Klinikum Stuttgart, Katharinenhospital Stuttgart, Germany Facharzt für Innere Medizin, Viersen, Germany Kliniken Nordoberpfalz AG - Klinikum Weiden Weiden, Germany 收起 <<
NCT02570789	Clear-cell Metastatic Renal Ce... 展开 >>ll Carcinoma 收起 <<	Phase 4	Active, not recruiting	December 2018	Belgium ... 展开 >> Cliniques universitaires Saint-Luc Brussel, Belgium, 1200 收起 <<
NCT00936832	Colorectal Cancer ... 展开 >> Metastatic Cancer 收起 <<	Phase 2	Withdrawn(because the sunitini... 展开 >>b showed futility in anotehr trial) 收起 <<	-	France ... 展开 >> Hopital Ambroise Pare Boulogne Billancourt, France, 92100 收起 <<
NCT03141177	Renal Cell Carcinoma	Phase 3	Recruiting	April 22, 2023	-
NCT00570908	Breast Cancer	Phase 2	Terminated(Due to poor accrual... 展开 >> this study is being closed to accrual) 收起 <<	-	United States, Texas ... 展开 >> Lester and Sue Smith Breast Center at Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT00570908	-		Terminated(Due to poor accrual... 展开 >> this study is being closed to accrual) 收起 <<	-	-
NCT03729245	Renal Cell Carcinoma ... 展开 >> Metastatic Renal Cell Carcinoma 收起 <<	Phase 3	Not yet recruiting	June 2024	United States, California ... 展开 >> Investigator Site - Whittier Not yet recruiting Whittier, California, United States, 90603 United States, Texas Investigator Site - Houston Not yet recruiting Houston, Texas, United States, 77030 United States, Virginia Investigator Site - Leesburg Not yet recruiting Leesburg, Virginia, United States, 20176 Australia, South Australia Investigator Site - Kurralta Park Not yet recruiting Kurralta Park, South Australia, Australia, 5037 收起 <<
NCT02401815	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 1 Phase 2	Active, not recruiting	March 2020	United States, Florida ... 展开 >> Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States, 33136 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio OSU Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 <<
NCT02230176	Pancreatic Neuroendocrine Carc... 展开 >>inoma 收起 <<	Phase 2	Recruiting	October 2023	France ... 展开 >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Lisa LAMBERT 0142116643 ext +33 lisa.lambert@gustaveroussy.fr Principal Investigator: Eric BAUDIN, MD, PhD 收起 <<
NCT00373256	Breast Neoplasms	Phase 3	Completed	-	-
NCT00054886	Kidney Neoplasms	Phase 2	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Mission Hills, California, United States, 91345 Pfizer Investigational Site Monterey Park, California, United States, 91754 Pfizer Investigational Site Northridge, California, United States, 91328 Pfizer Investigational Site San Francisco, California, United States, 94115 Pfizer Investigational Site San Francisco, California, United States, 94121 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 United States, Michigan Pfizer Investigational Site Ann Arbor, Michigan, United States, 48109 United States, Nevada Pfizer Investigational Site Henderson, Nevada, United States, 89052 Pfizer Investigational Site Las Vegas, Nevada, United States, 89109 Pfizer Investigational Site Las Vegas, Nevada, United States, 89128 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 收起 <<
NCT01381822	Advanced Renal Cell Carcinoma ... 展开 >> Gastrointestinal Stromal Tumors Pancreatic Neuroendocrine Tumors 收起 <<	Phase 1	Unknown	June 2014	United States, Indiana ... 展开 >> IU Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 收起 <<
NCT01371201	Malignant Progressive Pheochro... 展开 >>mocytoma and Paraganglioma (PPGL) 收起 <<	Phase 2	Recruiting	June 2021	France ... 展开 >> Institut de Cancérologie Gustave roussy Recruiting Villejuif, France, 94805 Contact: Eric Baudin, MD eric.baudin@igr.fr Principal Investigator: Eric Baudin, MD Sub-Investigator: Martin Schlumberger, MD Sub-Investigator: Sophie Leboulleux, MD Sub-Investigator: Cécile Chougnet, MD Germany Universitätsklinikum Würzburg Recruiting Würburg, Germany, 97080 Contact: Martin FASSNACHT, MD 0931-201-39021 Principal Investigator: Martin FASSNACHT, MD Italy University of Padova Recruiting Padova, Italy, 35128 Contact: Giusepe OPOCHER, MD 0498215503 ext +39 Principal Investigator: Giusepe OPOCHER, MD Netherlands Radboud University Nijmegen Medical Centre Recruiting Nijmegen, GA, Netherlands, 6525 Contact: Henry TIMMERS, MD 0243614599 ext +31 Principal Investigator: Henry TIMMERS, MD 收起 <<
NCT00094029	-		-	-	-
NCT00555672	-		Completed	-	-
NCT00616122	Breast Cancer	Phase 1 Phase 2	Completed	-	United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 收起 <<
NCT00373256	-		Completed	-	-
NCT01246778	-		Completed	-	Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB 收起 <<
NCT00748358	Prostatic Neoplasms ... 展开 >> Neoplasms, Hormone-Dependent Tumor Markers, Biological Survival Rate Disease-Free Survival 收起 <<	Phase 2	Completed	-	France ... 展开 >> Service Oncologie Médicale, Hopital Europeen Georges Pompidou Paris, France, 75015 收起 <<
NCT00555672	Stomach Neoplasms	Phase 1	Completed	-	Spain ... 展开 >> Pfizer Investigational Site L'hospitalet de Llobregat, Barcelona, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28041 收起 <<
NCT00616122	-		Completed	-	-
NCT01664182	Stage III Renal Cell Cancer AJ... 展开 >>CC v7 Stage IV Renal Cell Cancer AJCC v7 收起 <<	Phase 2	Active, not recruiting	-	United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States, 55416 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Virginia VCU Massey Cancer Center at Hanover Medical Park Mechanicsville, Virginia, United States, 23116 收起 <<
NCT00372853	Carcinoma, Renal Cell	Phase 1	Completed	-	United States, Arizona ... 展开 >> Research Site Scottsdale, Arizona, United States, 85258 United States, New Jersey Research Site New Brunswick, New Jersey, United States, 08903 United States, Ohio Research Site Cleveland, Ohio, United States, 44195 United States, South Carolina Research Site Greenville, South Carolina, United States, 29605 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 收起 <<
NCT00113516	Non-small Cell Lung Cancer	Phase 2	Completed	-	-
NCT00130897	-		-	-	-
NCT00137423	Carcinoma, Renal Cell Metastas... 展开 >>is 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Stanford, California, United States, 94305 United States, Nevada Pfizer Investigational Site Las Vegas, Nevada, United States, 89135 France Pfizer Investigational Site Villejuif, France, 94805 Germany Pfizer Investigational Site Berlin, Germany, 10117 Pfizer Investigational Site Muenchen, Germany, 81664 Greece Pfizer Investigational Site Thessaloniki, Greece, 56429 Netherlands Pfizer Investigational Site Nijmegen, Gld, Netherlands, 6525 GA Sweden Pfizer Investigational Site Lund, Sweden, SE-221 85 Pfizer Investigational Site Stockholm, Sweden, 171 76 Switzerland Pfizer Investigational Site St. Gallen, Switzerland, CH-9007 收起 <<
NCT00430261	Lung Cancer A... 展开 >>denocarcinoma 收起 <<	Phase 2	Completed	-	United States, Washington ... 展开 >> Swedish Cancer Institute Seattle, Washington, United States, 98104 收起 <<
NCT01694277	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 3	Recruiting	December 2022	France ... 展开 >> Institut Bergonié Recruiting Bordeaux, France, 33000 收起 <<
NCT00083889	-		Completed	-	-
NCT00137423	-		Completed	-	-
NCT00243503	-		Completed	-	-
NCT00113516	-		Completed	-	-
NCT01459757	-		Completed	-	-
NCT00631410	Colorectal Neoplasms	Phase 1	Completed	-	Japan ... 展开 >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Suntougun, Shizuoka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan 收起 <<
NCT00083889	Carcinoma, Renal Cell	Phase 3	Completed	-	-
NCT00631410	-		Completed	-	-
NCT02187042	-		Completed	-	France ... 展开 >> CHU de la Timone Marseille, Cedex 5, France, 13335 CHU Strasbourg Strasbourg, Cedex, France, 67091 Centre Hospitalier d'Annecy Annecy Cedex, France, 74011 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre hospitalier de Chambery Chambery, France, 73000 Hopital prive La Louviere Lille, France, 59042 Clinique Claude Bernard Chimiotherapie Ambulatoire Metz, France, 57000 CRLC Val d'Aurelle Montpellier cedex 05, France, 34295 Polyclinique Gentilly Nancy, France, 54000 Polyclinique de Gentilly Service Oncologie Médicale Nancy, France, 54100 CHI de Cornouailles - Oncologie hospitalisation Quimper Cedex, France, 29107 Hopital Jean BERNARD - Tours - 7eme etage Valenciennes, France, 59300 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 收起 <<
NCT00371553	Relapsed or Cisplatin-Refracto... 展开 >>ry Germ Cell Cancer 收起 <<	Phase 2	Completed	-	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T4N 4N2 Canada, British Columbia BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Science Center Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 收起 <<
NCT00904657	Blood Pressure	Phase 1	Completed	-	-
NCT00531544	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Not Applicable	Completed	-	Saudi Arabia ... 展开 >> KFSH&RC Riyadh, Saudi Arabia, 1211 收起 <<
NCT00676650	Prostatic Neoplasms	Phase 3	Terminated(Study A6181120 was ... 展开 >>prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.) 收起 <<	-	-
NCT02019576	Clear Cell Metastatic Renal Ce... 展开 >>ll Carcinoma 收起 <<	Phase 2	Recruiting	December 2019	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Gerald Lim, MD Gerald.Lim@albertahealthservices.ca Principal Investigator: Gerald Lim, MD Sub-Investigator: Daniel Heng, MD Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Samir Patel, MD Samir.Patel2@albertahealthservices.ca Principal Investigator: Samir Patel, MD Sub-Investigator: Scott North, MD Canada, British Columbia BC Cancer Agency Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Christian Kollmannsberger, MD ckollmannsberger@bccancer.bc.ca Principal Investigator: Christian Kollmannsberger, MD Canada, Manitoba Manitoba CancerCare Institute Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: Arbind Dubey, MD adubey@cancercare.mb.ca Sub-Investigator: Piotr Czaykowski, MD Principal Investigator: Arbind Dubey, MD Canada, Nova Scotia QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Contact: Lori Wood, MD lori.wood@cdha.nshealth.ca Principal Investigator: Lori Wood, MD Sub-Investigator: Derek Wilke, MD Canada, Ontario Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Anand Swaminath, MD Anand.swaminath@jcc.hhsc.ca Principal Investigator: Anand Swaminath, MD Sub-Investigator: Sebastian Hotte, MD London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 4L6 Contact: Belal Ahmad, MD Belal.Ahmad@lhsc.on.ca Principal Investigator: Belal Ahmad, MD Sub-Investigator: George Rodrigues, MD Ottawa Hospital Cancer Centre Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Scott Morgan, MD smorgan@Ottawahospital.on.ca Principal Investigator: Scott Morgan, MD Sub-Investigator: Christina Canil, MD Odette Cancer Centre, Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Georg Bjarnason, MD, FRCPC 416-480-5847 georg.bjarnason@sunnybrook.ca Contact: Nesan Bandali, RN 416-480-6100 ext 82139 nesan.bandali@sunnybrook.ca Principal Investigator: Georg Bjarnason, MD, FRCPC Principal Investigator: Patrick Cheung, MD Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Srikala Sridhar, MD srikala.sridhar@uhn.on.ca Principal Investigator: Srikala Sridhar, MD Sub-Investigator: Anthony Brade, MD Canada, Quebec McGill University Health Centre Recruiting Montreal, Quebec, Canada, H3G 1A4 Contact: Fabio Cury, MD fabio.cury@gmail.com Principal Investigator: Fabio Cury, MD Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Tamim Niazi, MD tniazi@jgh.mcgill.ca Principal Investigator: Tamim Niazi, MD 收起 <<
NCT00982657	Solid Tumor	Phase 2	Terminated(Refer to statement ... 展开 >>in Summary Section/Detailed Description) 收起 <<	-	United States, Arizona ... 展开 >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85258 United States, California Premiere Oncology, A Medical Corporation Santa Monica, California, United States, 90404 United States, Mississippi Boston Baskin Cancer Foundation Southaven, Mississippi, United States, 38671 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Tennessee Boston Baskin Cancer Foundation Bartlett, Tennessee, United States, 38133 Boston Baskin Cancer Foundation Germantown, Tennessee, United States, 38138 Boston Baskin Cancer Foundation Memphis, Tennessee, United States, 38120 收起 <<
NCT00673504	Pancreatic Cancer	Phase 2	Completed	-	Germany ... 展开 >> Städtisches Klinikum Braunschweig Braunschweig, Germany, 38114 Universitätsklinikum Essen Essen, Germany, 45122 Krankenhaus Frankfurt, Germany, 60488 Klinikum der J. W. Goethe Universität; Zentrum der Inneren Medizin Frankfurt, Germany, 60590 Internistisches Facharztzentrum Frankfurt, Germany, 60596 Martin-Luther-Universität Halle-Wittenberg; Medizinische Fakultät Halle (Saale), Germany, 06097 Facharztpraxis Heidelberg, Germany, 69115 Klinikum Lüdenscheid Luedenscheid, Germany, 58515 Klinikum Nürnberg Nord Nürnberg, Germany, 90419 Robert-Bosch-Krankenhaus Stuttgart, Germany, 70376 Switzerland Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 收起 <<
NCT00982657	-		Terminated(Refer to statement ... 展开 >>in Summary Section/Detailed Description) 收起 <<	-	-
NCT01024920	Carcinoma, Renal Cell	Phase 2	Active, not recruiting	February 15, 2019	Hungary ... 展开 >> University of Pecs Medical School, Dept. of Oncotherapy Pecs, Hungary, 7624 Poland Ziemia Lubelska Oncological Center, Lublin Lublin, Poland, 20-099 Onco.Cent. - Instit. of Maria Sklodowskiej-Curie Warszawa, Poland, 02-781 Romania Military Central Clinical Emergency Hospital Bucharest, Romania, 010825 Sf. Nectarie Oncology Center, Craiova Craiova, Romania, 200347 ONCOLAB SRL, Craiova Craiova, Romania, 200385 Ukraine Municipal Establishment Cherkasy Oncology Centre Cherkasy, Ukraine, 18009 Bukovynsk State Medical University Chernivtsi, Ukraine, 58013 City Clinical Hospital #4, Dnipropetrovsk State Medical Academy Dnipropetrovks, Ukraine, 49102 CI of LRC Lviv Onco.Reg.Treat.&Diag.Cent. Lviv, Ukraine, 79031 Uzhgorod National University, Oncology Centre Uzhgorod, Ukraine, 88000 United Kingdom Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Surrey Cancer Research Institute Guildford, United Kingdom, GU2 7WG St James's University Hospital Leeds, United Kingdom, LS9 7TF 收起 <<
NCT00513695	Inflammatory Breast Cancer ... 展开 >> Male Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer 收起 <<	Phase 2	Active, not recruiting	-	United States, Alaska ... 展开 >> Anchorage Oncology Centre Anchorage, Alaska, United States, 99508 Katmai Oncology Group Anchorage, Alaska, United States, 99508 United States, Arizona Arizona Cancer Center Tucson, Arizona, United States, 85724-5024 United States, Idaho Saint Luke's Mountain States Tumor Institute Boise, Idaho, United States, 83712 United States, Washington Skagit Valley Hospital Mount Vernon, Washington, United States, 98273 Olympic Medical Center Port Angeles, Washington, United States, 98362 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 <<
NCT03091192	Carcinoma Car... 展开 >>cinoma, Renal Cell Kidney Neoplasms Urologic Neoplasms Kidney Diseases Neoplasms by Site Enzyme Inhibitors Protein Kinase Inhibitors 收起 <<	Phase 3	Active, not recruiting	June 24, 2020	-
NCT00243503	Breast Neoplasms	Phase 2	Completed	-	-
NCT00375674	Kidney Neoplasms	Phase 3	Completed	-	-
NCT00513695	-		Active, not recruiting	-	-
NCT02450123	Refractory Solid Tumors	Not Applicable	Recruiting	December 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Joon Oh Park, M.D., Ph.D 82 2 3410 3459 oncopark@skku.edu Contact: yoon Jeong Ahn 221487395 ext 82 收起 <<
NCT00522249	Carcinoma, Renal Cell	Phase 1 Phase 2	Terminated(PI decision)	-	United States, Texas ... 展开 >> Baylor College of Medicine - Methodist Hospital Houston, Texas, United States, 77030 收起 <<
NCT00541008	Kidney Cancer	Phase 2	Unknown	-	France ... 展开 >> Centre Paul Papin Recruiting Angers, France, 49036 Contact: Sophie Abadie-Lacourtoisie, MD 33-2-4135-2734 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Recruiting Besancon, France, 25030 Contact: Ulrich Stein, MD 33-3-8166-8240 Hopital Saint Andre Recruiting Bordeaux, France, 33075 Contact: Alain Ravaud, MD, PhD 33-5-5679-5808 alain.ravaud@chu-bordeaux.fr C.H.U. de Brest Recruiting Brest, France, 29609 Contact: Jean-Pierre Malhaire, MD 33-2-9822-3395 Centre Regional Francois Baclesse Recruiting Caen, France, 14076 Contact: Emmanuel Sevin, MD 33-2-3145-5017 e.sevin@baclesse.fr CHU de Grenoble - Hopital de la Tronche Recruiting Grenoble, France, 38043 Contact: Matthieu Laramas, MD 33-4-7676-5333 Centre Hospitalier Departemental Recruiting La Roche Sur Yon, France, 85025 Contact: Franck Priou, MD 33-2-5144-6173 frank.priou@chd-vendee.fr Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD 33-3-2029-5942 acaty@o-lambret.fr Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Sylvie Negrier, MD 33-4-7878-2751 negrier@lyon.fnclcc.fr Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle Gravis, MD 33-4-9122-3740 gravisg@marseille.fnclcc.fr CHU de la Timone Recruiting Marseille, France, 13385 Contact: Marjorie Baciuchka-Palmaro 33-91-385-708 Hopital Notre-Dame de Bon Secours Recruiting Metz, France, 57038 Contact: Sabine Walter, MD 33-387-553-554 s.walter@chr-metz-thionville.rss.fr Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD 33-4-6761-8555 stculine@valdorel.fnclcc.fr CRLCC Nantes - Atlantique Recruiting Nantes-Saint Herblain, France, 44805 Contact: Frederic Rolland, MD 33-2-40-67-99-76 F-rolland@nantes.fnclcc.fr Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Jean Marc Ferrero, MD 33-4-9203-1511 jean-marc.ferrerero@nice.fnclcc.fr Hopital Europeen Georges Pompidou Recruiting Paris, France, 75015 Contact: Stephane Oudard, MD, PhD 33-1-5609-3434 stephane.oudard@hop.egp.ap-hop-paris.fr Hopital Saint Michel Recruiting Paris, France, 75015 Contact: Gael Deplanque, MD, MSC, PhD 33-1-4412-3078 Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Herve Cure, MD, PhD 33-3-2650-4382 Hopital Foch Recruiting Suresnes, France, 92151 Contact: Christine Theodore, MD 33-1-4625-2149 Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Christine Chevreau-Dalbianco, MD 33-5-6142-4118 chevreau.christine@claudiusregaud.fr Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Claude Linassier, MD, PhD 33-2-4747-3827 linassier@med.univ-tours.fr Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Bernard Escudier, MD 33-1-4211-5410 escudier@igr.fr 收起 <<
NCT00676650	-		Terminated(Study A6181120 was ... 展开 >>prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.) 收起 <<	-	-
NCT01176799	Breast Cancer	Phase 2	Unknown	December 2017	Singapore ... 展开 >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Soo Chin Lee, MBBS, MRCP 65 6772 4629 Soo_Chin_Lee@nuhs.edu.sg Principal Investigator: Soo Chin Lee, MBBS, MRCP National University Hospital Recruiting Singapore, Singapore, 119228 收起 <<
NCT00953459	Lung Cancer	Phase 2	Terminated(poorly recruiting)	-	Netherlands ... 展开 >> Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1007 MB 收起 <<
NCT00555620	Stomach Neoplasms	Phase 1	Completed	-	Korea, Republic of ... 展开 >> Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Goyang, Gyeonggi, Korea, Republic of, 410-769 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 收起 <<
NCT00393939	Breast Neoplasms	Phase 3	Completed	-	-
NCT00748163	Lung Cancer	Phase 2	Withdrawn(Study has been aband... 展开 >>oned for lack of available funding.) 收起 <<	August 2008	-
NCT00393939	-		Completed	-	-
NCT00599924	Colorectal Neoplasms ... 展开 >> Neoplasms 收起 <<	Phase 1	Completed	-	United States, Colorado ... 展开 >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75246 收起 <<
NCT00792025	Bladder Cancer ... 展开 >> Transitional Cell Cancer of the Renal Pelvis and Ureter 收起 <<	Phase 2	Completed	-	France ... 展开 >> Centre Rene Huguenin Saint Cloud, France, 92211 Hopital Foch Suresnes, France, 92151 收起 <<
NCT01258348	Metastatic Renal Cell Cancer	Phase 1	Completed	-	United States, Indiana ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46219 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States, 29605 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada, H3T 1E2 收起 <<
NCT00555620	-		Completed	-	-
NCT00375674	-		Completed	-	-
NCT01258348	-		Completed	-	-
NCT01984242	Renal Cell Carcinoma	Phase 2	Active, not recruiting	August 31, 2019	-
NCT00589784	CNS Cancer Me... 展开 >>ningioma Intracranial Hemangiopericytoma Hemangioblastoma Neurofibromatosis 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburg, Pennsylvania, United States United States, Virginia University of Virginia Health Science Center Charlottesville, Virginia, United States, 22908 收起 <<
NCT00411151	Gastric Adenocarcinoma ... 展开 >> Barrett Esophagus 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> Universität Heidelberg, Nationales Zentrum für Tumorerkrankungen Heidelberg, Baden-Würtemberg, Germany, 69120 Universitätsklinikum Tübingen Tübingen, Baden-Würtemberg, Germany, 72076 TU München, Klinikum rechts der Isar, II. Med. Klinik und Poliklinik München, Bayern, Germany, 81675 Klinikum der Universität Würzburg Würzburg, Bayern, Germany, 97070 Universitätsklinikum der GHS Essen, Innere Klinik und Poliklinik, Tumorforschung Essen, Nordrhein-Westfalen, Germany, 45122 Universitätsklinik zu Köln, Klinik I für Innere Medizin Köln, Nordrhein-Westfalen, Germany, 50937 Klinikum der Johannes Gutenberg-Universität Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Universitätsklinikum des Saarlandes Homburg/Saar, Saarland, Germany, 66421 Otto-von-Guericke-Universität Magdeburg Magdeburg, Sachsen-Anhalt, Germany, 39120 Universitätsklinikum Carl Gustav Carus, Med. Klinik I Dresden, Sachsen, Germany, 01307 Charité, Campus Benjamin Franklin Berlin, Germany, 12200 KH Nordwest, Abteilung für Hämatologie und Onkologie Frankfurt, Germany, 60488 收起 <<
NCT01984242	-		Active, not recruiting	-	-
NCT00428597	Carcinoma, Islet Cell ... 展开 >> Carcinoma, Pancreas 收起 <<	Phase 3	Terminated(Refer to Detailed D... 展开 >>escription.) 收起 <<	-	-
NCT00599924	-		Completed	-	-
NCT01472081	Renal Cell Carcinoma ... 展开 >> Clear-cell Metastatic Renal Cell Carcinoma 收起 <<	Phase 1	Active, not recruiting	June 2018	United States, California ... 展开 >> City Of Hope Duarte, California, United States, 91010 United States, Maryland Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Tennessee Oncology, Pllc Nashville, Tennessee, United States, 37203 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Alberta Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia Bc Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Princess Margaret Hospital-Uhn Toronto, Ontario, Canada, M5G 2M9 收起 <<
NCT00411151	-		Completed	-	-
NCT00589784	-		Completed	-	-
NCT00428597	-		Terminated(Refer to Detailed D... 展开 >>escription.) 收起 <<	-	-
NCT01446224	-		Completed	-	-
NCT01039519	Gastrointestinal Stromal Tumor	Phase 2	Completed	-	United States, California ... 展开 >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health and Science University-Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 收起 <<
NCT01468688	3rd Line GIST	Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States, 02215 United States, Washington Seattle Cancer Care Alliance Onc Seattle, Washington, United States, 98105 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Villejuif Cedex, France, 94805 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site London, United Kingdom, SW3 6JJ Novartis Investigative Site Manchester, United Kingdom, M20 9BX 收起 <<
NCT01735968	3rd Line GIST	Phase 1	Completed	-	United States, Oregon ... 展开 >> Oregon Health and Science University Dept. of OHSU (3) Portland, Oregon, United States, 97239 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux, France, 33076 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Essen, Germany, 45122 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Candiolo, TO, Italy, 10060 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site Leeds, United Kingdom, LS9 7TF 收起 <<
NCT00618319	GIST	Phase 2	Completed	-	United States, California ... 展开 >> Reseach Facility Encinitas, California, United States Research Site Santa Monica, California, United States, 90404 United States, Texas Reseach Facility San Antonio, Texas, United States 收起 <<
NCT00511511	-		Completed	-	Netherlands ... 展开 >> Erasmus MC Rotterdam, Netherlands, 3015 CE 收起 <<
NCT01689376	-		-	-	-
NCT01646593	-		-	-	-
NCT02268435	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 1	Withdrawn(Dovitinib Production... 展开 >> stopped) 收起 <<	November 2016	-
NCT02013089	Gastrointestinal Cancers	Not Applicable	Unknown	December 2017	China, Guangdong ... 展开 >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD 008613925106525 13925106525@163.com Principal Investigator: Yanhong Deng, PhD 收起 <<
NCT02560012	Carcinoma, Renal Cell	Phase 2	Terminated(Loss of laboratory ... 展开 >>performing molecular analysis) 收起 <<	-	United States, Texas ... 展开 >> UTHealth Memorial Hermann Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT01039519	-		Completed	-	-
NCT01860118	-		Completed	-	United States, Alabama ... 展开 >> University of Alabama at Birmingham Sparks Center Birmingham, Alabama, United States, 35294 收起 <<
NCT02560012	-		Terminated(Loss of laboratory ... 展开 >>performing molecular analysis) 收起 <<	-	-
NCT00410124	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 3	Completed	-	-
NCT01219023	Hand Foot Syndrome ... 展开 >> Palmar Plantar Erythrodysesthesia 收起 <<	Phase 1	Completed	-	United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 <<
NCT02779283	Acute Lymphoblastic Leukemia ... 展开 >> Acute Myeloid Leukemia 收起 <<	Phase 1	Recruiting	June 1, 2019	United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon 503-494-8950 spurgeos@ohsu.edu Principal Investigator: Stephen E. Spurgeon 收起 <<
NCT01582672	Advanced Renal Cell Carcinoma ... 展开 >> Renal Cell Carcinoma Metastatic Renal Cell Carcinoma 收起 <<	Phase 3	Terminated(Lack of efficacy)	-	-
NCT01441388	Carcinoma, Renal Cell ... 展开 >> Glioblastoma Carcinoma, Hepatocellular 收起 <<	Phase 1	Withdrawn(Business/Operational... 展开 >> issues) 收起 <<	November 2013	-
NCT01731158	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Unknown	May 2016	Germany ... 展开 >> Charité Berlin Berlin, Germany University Hospital Bonn Bonn, Germany University Hospital Dresden Dresden, Germany University Hospital Düsseldorf Düsseldorf, Germany Waldkrankenhaus St. Marien Erlangen, Germany University Hospital Essen Essen, Germany University Hospital Frankfurt Frankfurt, Germany University Hospital Freiburg Freiburg, Germany University Hospital Göttingen Göttingen, Germany Oncological Practice Hannover Hannover, Germany University Hospital Hannover Hannover, Germany University Hospital Magdeburg Magdeburg, Germany University Hospital Tübingen Tübingen, Germany 收起 <<
NCT01306045	Carcinoma, Non-Small-Cell Lung... 展开 >> Carcinoma, Small Cell Lung Carcinoma, Thymic 收起 <<	Phase 2	Recruiting	December 30, 2019	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office (888) NCI-1937 收起 <<
NCT00891475	Carcinoma, Renal Cell	Phase 1 Phase 2	Completed	-	Russian Federation ... 展开 >> Ilya Tsimafeyeu Moscow, Russian Federation, 109147 收起 <<
NCT02187302	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Completed	-	-
NCT01271712	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 3	Active, not recruiting	May 31, 2019	-
NCT00410124	-		Completed	-	-
NCT02068170	-		Completed	-	Belgium ... 展开 >> UZ Leuven Leuven, Belgium, 3000 收起 <<
NCT01271712	-		Active, not recruiting	-	-
NCT02239952	Cancer High-g... 展开 >>rade Glioma 收起 <<	Not Applicable	Recruiting	January 2019	Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: H.M.W Verheul, MD, PhD +31 (0)20 4444321 h.verheul@vumc.nl 收起 <<
NCT02216578	Metastatic Gastrointestinal St... 展开 >>romal Tumor 收起 <<	Phase 2	Recruiting	August 2019	Belgium ... 展开 >> U.Z. Leuven - Campus Gasthuisberg (147) Recruiting Leuven, Belgium Contact: Patrick Schöffski Czechia University Hospital Motol (1905) Recruiting Prague, Czechia Contact: Katerina Kopeckova-Kubackova France Institut Bergonie (228) Recruiting Bordeaux, France Contact: Antoine Italiano Centre Leon Berard (227) Recruiting Lyon, France Contact: Jean-Yves Blay Gustave Roussy (225) Recruiting Villejuif, France Contact: Olivier Mir Germany UniversitaetsMedizin Mannheim (527) Recruiting Mannheim, Germany Contact: Bernd Kasper Hungary Military Hospital - State Health Centre (3769) Recruiting Budapest, Hungary Contact: Zsuzanna papai United Kingdom Clatterbridge Centre for Oncology NHS Trust - Clatterbridge Cancer Centre NHS Foundation Trust (659) Recruiting Bebington, United Kingdom Contact: Ali Nasim Royal Marsden Hospital - Chelsea, London (613) Recruiting Chelsea, United Kingdom Contact: Charlotte Benson University College London Hospitals NHS Foundation Trust - University College Hospital (622) Recruiting London, United Kingdom Contact: Palma Dileo The Christie NHS Foundation Trust (610) Not yet recruiting Manchester, United Kingdom Contact: Michael Leahy 收起 <<
NCT00782834	-		Terminated(Stopped early for f... 展开 >>utility, unable to meet accrual goals) 收起 <<	-	-
NCT02889328	Gastrointestinal Stromal Tumor... 展开 >>s (GISTs) 收起 <<	Phase 2	Completed	-	Korea, Republic of ... 展开 >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 <<
NCT00914043	-		Withdrawn(Withdrawn as NCI res... 展开 >>cinded approval for parent study NSABP-B-45) 收起 <<	-	-
NCT01190241	Advanced Solid Tumors ... 展开 >> Inoperable Metastasis 收起 <<	Not Applicable	Unknown	-	Netherlands ... 展开 >> Medical Center Alkmaar Alkmaar, Netherlands, 1815 JD VU University Medical Center Amsterdam, Netherlands, 1081 HV 收起 <<
NCT01323400	GIST	Phase 2	Completed	-	France ... 展开 >> Institut Bergonié Bordeaux, France Centre Georges François Leclerc Dijon, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France, F-69008 Hôpital de la Timone Marseille, France Institut Paoli Calmette Marseille, France Centre Alexis Vautrin Nancy, France Institut de Cancérologie de l'Ouest Nantes, France Hôpital St Antoine Paris, France Hôpital Tenon Paris, France CHU de Reims Reims, France Institut Cancerologie Neuwirth St Priest en Jarez, France Institut Gustave Roussy Villejuif, France 收起 <<
NCT01502228	Renal Cell Carcinoma	Not Applicable	Terminated(No further funding)	-	United States, Indiana ... 展开 >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 收起 <<
NCT00782834	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Terminated(Stopped early for f... 展开 >>utility, unable to meet accrual goals) 收起 <<	-	United States, Pennsylvania ... 展开 >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 <<
NCT01502228	-		Terminated(No further funding)	-	-
NCT00731211	Renal Cell Carcinoma	Phase 2	Completed	-	United States, California ... 展开 >> San Francisco Oncology Associates San Francisco, California, United States, 94115 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maine Central Maine Medical Center Lewiston, Maine, United States, 04240 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 收起 <<
NCT02848768	-		Completed	-	France ... 展开 >> CHU de Rennes Rennes, France, 35033 收起 <<
NCT01068769	Gastrointestinal Stromal Tumor	Phase 2	Active, not recruiting	December 2018	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 <<
NCT00731211	-		Completed	-	-
NCT02264665	-		Recruiting	June 5, 2019	-
NCT01440959	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Completed	-	Korea, Republic of ... 展开 >> Asan Medical Center, University of Ulsan College of Medicine Seoul,, Korea, Republic of, 138-736 收起 <<
NCT01440959	-		Completed	-	-
NCT01449825	-		Completed	-	-
NCT03062410	Renal Carcinoma Metastatic ... 展开 >> Kidney Neoplasms Renal Cancer 收起 <<	Not Applicable	Recruiting	February 4, 2020	France ... 展开 >> CHU de Besançon Active, not recruiting Besançon, France, 25030 Hôpital privé Sainte Marie Recruiting Chalon-sur-Saône, France, 71100 Contact: Erika Viel, MD 0033385488989 Centre de lutte contre le cancer Georges François Leclerc Recruiting Dijon, France, 21000 Contact: Sylvain Ladoire, MD 0033380737506 sladoire@cgfl.fr Hôpital Nord Franche-Comté Recruiting Montbéliard, France, 25200 Contact: Guillaume Mouillet, MD mouillet.guillaume@gmail.com Centre de lutte contre le cancer Jean Godinot Recruiting Reims, France, 51100 Contact: Jean-Christophe Eymard, MD Groupe hospitaliser St-Vincent Recruiting Strasbourg, France, 67000 Contact: Louis-Marie Dourthe, MD lm.dourthe@solcrr.org Hôpitaux Universitaires de Strasbourg Recruiting Strasbourg, France, 67000 Contact: Philippe Barthelemy, MD philippe.barthelemy@chru-strasbourg.fr Centre de lutte contre le cancer Alexis Vautrin - Institut de Cancérologie de Lorraine Recruiting Vandœuvre-lès-Nancy, France, 54519 Contact: Lionnel Geoffrois, MD l.geoffrois@nancy.unicancer.fr 收起 <<
NCT01482949	Renal Cell Carcinoma	Phase 2	Terminated(Lack of efficacy)	-	United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 <<
NCT01566747	Renal Cell Carcinoma	Phase 2	Active, not recruiting	September 2018	Ireland ... 展开 >> Beaumont Hospital Dublin, Leinster, Ireland Mater Misericordiae University Hospital Dublin, Leinster, Ireland Mater Private Hospital Dublin, Leinster, Ireland Cork University Hospital Cork, Ireland The Adelaide & Meath Hospital Dublin incorporating the National Children's Hospital Dublin, Ireland Galway University Hospital Galway, Ireland Mid-Western Regional Hospital Limerick, Ireland Waterford Regional Hospital Waterford, Ireland Sweden Karolinska University Hospital Stockholm, Sweden 收起 <<
NCT01068769	-		Active, not recruiting	-	-
NCT02607332	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Completed	-	Korea, Republic of ... 展开 >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 <<
NCT03609424	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 1 Phase 2	Not yet recruiting	August 30, 2020	-
NCT02380625	Ebola Virus Disease	Phase 1 Phase 2	Unknown	March 2016	-
NCT01620216	Acute Myeloid Leukemia Arising... 展开 >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia 收起 <<	Phase 2	Recruiting	March 30, 2019	United States, Maryland ... 展开 >> National Heart Lung and Blood Institute Not yet recruiting Bethesda, Maryland, United States, 20824 Contact: Christopher S. Hourigan 301-803-8029 hourigan@nih.gov Principal Investigator: Christopher S. Hourigan United States, Oregon OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Marc Loriaux 503-494-9383 loriauxm@ohsu.edu Principal Investigator: Marc Loriaux United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Robert H. Collins 214-648-4155 robert.collins@utsouthwestern.edu Principal Investigator: Robert H. Collins United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Tibor J. Kovacsovics 801-585-3229 tibor.kovacsovics@hci.utah.edu Principal Investigator: Tibor J. Kovacsovics 收起 <<
NCT00976612	-		Completed	-	Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 <<
NCT01058044	Cancer	Not Applicable	Completed	-	France ... 展开 >> Centre Jean Perrin Clermont-Ferrand, France, 63011 收起 <<
NCT00495872	Solid Tumors	Phase 1	Completed	-	United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT01151852	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 3	Completed	-	Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 收起 <<
NCT02960906	Clear Cell Metastatic Renal Ce... 展开 >>ll Carcinoma 收起 <<	Phase 2	Recruiting	May 2020	France ... 展开 >> Hôpital Saint André, CHU de Bordeaux Recruiting Bordeaux, France, 33075 Contact: Marine GROSS-GOUPIL, MD marine.gross-goupil@chu-bordeaux.fr Centre Francois Baclesse Recruiting Caen, France, 14000 Contact: Florence JOLY, MD,PHD f.joly@baclesse.unicancer.fr CHU Henri-Mondor Recruiting Creteil, France, 94000 Contact: Christophe TOURNIGAND, MD, PHD christophe.tournigand@aphp.fr CHD Vendée Not yet recruiting La Roche-sur-Yon, France, 85925 Contact: Franck PRIOU, MD frank.priou@chd-vendee.fr Centre OSCAR LAMBRET LILLE Recruiting Lille, France, 59000 Contact: Yaovi Messan AMELA, MD e-amela@o-lambret.fr Hôpital Européen Marseille Not yet recruiting Marseille, France, 13003 Contact: Philippe DALIVOUST philippe.dalivoust@gmail.com Institut Paoli Calmettes (IPC) Recruiting Marseille, France, 13009 Contact: Gwenaëlle GRAVIS, MD gravisg@ipc.unicancer.fr Centre Antoine Lacassagne Recruiting Nice, France, 06100 Contact: Delphine BORCHIELLINI, MD Delphine.BORCHIELLINI@nice.unicancer.fr Institut de Cancérologie du Gard - CHU Caremeau Recruiting Nîmes, France, 30029 Contact: Nadine HOUEDE, MD,PHD HOUEDE nadine Hôpital Pitié-Salpêtrière Withdrawn Paris, France, 75013 Institut Mutualiste Montsouris Recruiting Paris, France, 75014 Contact: Mostefa BENNAMOUN, MD Mostefa.Bennamoun@imm.fr Hôpital Européen Georges Pompidou Recruiting Paris, France, 75015 Contact: Yann-Alexandre VANO, MD yann.vano@aphp.fr Hôpital de la Croix Saint-Simon Not yet recruiting Paris, France, 75020 Contact: Jacques MEDIONI JMedioni@hopital-dcss.org Hôpital Cochin Recruiting Paris, France, 75679 Contact: Olivier HUILLARD, MD olivier.huillard@aphp.fr Centre Hospitalier Lyon Sud - Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL) Not yet recruiting Pierre Bénite, France, 69310 Contact: Denis MAILLET, MD denis.maillet@chu-lyon.fr Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Brigitte LAGUERRE, MD b.laguerre@rennes.unicancer.fr Centre René Gauducheau ICO institut de Cancerologie de l'Ouest Not yet recruiting Saint-Herblain, France, 44805 Contact: Frédéric ROLLAND, MD Frederic.Rolland@ico.unicancer.fr Hôpitaux universitaires de Strasbourg Recruiting Strasbourg, France, 67000 Contact: Philippe BARTHELEMY, MD philippe.barthelemy@chru-strasbourg.fr Hopital Foch Not yet recruiting Suresnes, France, 92151 Contact: Philippe BEUZEBOC beuzeboc.philippe@gmail.com Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD Chevreau.Christine@iuct-oncopole.fr CHU Bretonneau Recruiting Tours, France, 37000 Contact: Claude LINASSIER, MD claude.linassier@univ-tours.fr Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Laurence ALBIGES, MD Laurence.ALBIGES@gustaveroussy.fr 收起 <<
NCT01389583	Gastrointestinal Stromal Tumor	Phase 2	Recruiting	October 2019	Taiwan ... 展开 >> National Health Research of Institutes, Taiwan Cooperative Oncology Group Recruiting Tainan, Taiwan Principal Investigator: Kun-Huei Yeh, PhD Principal Investigator: Chueh-Chuan Yen, PhD Principal Investigator: Ken-Hong Lim, MD Principal Investigator: Jen-Shi Chen Principal Investigator: Cheng-Chung Wu, MS Principal Investigator: Chang-Fang Chiu, PhD Principal Investigator: Kuan-Der Lee, PhD Principal Investigator: Kun-Ming Rau, MPH Sub-Investigator: Ann-Lii Cheng, PhD Sub-Investigator: Yu-Lin Lin, MD Sub-Investigator: Ta-Chung Chao, MD Sub-Investigator: Wen-Liang Fang, MD Sub-Investigator: Ruey-Kuen Hsieh, MD Sub-Investigator: Chun-Nan Yeh, MD Sub-Investigator: Youngsen Yang, MD Sub-Investigator: Tseng-Hsi Lin, PhD Sub-Investigator: Mei-Due Yang, PhD Sub-Investigator: Li-Yuan Bai, MD Sub-Investigator: Wu-Chou Su, MD Sub-Investigator: Yan-Shen Shan, PhD Sub-Investigator: Nai-Jung Chiang, MD Sub-Investigator: Yen-Yang Chen, MD 收起 <<
NCT01977586	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Not Applicable	Withdrawn(Difficulty in recrui... 展开 >>ting suitable patients at centre) 收起 <<	-	United Kingdom ... 展开 >> Imperial College Healthcare NHS Trust London, United Kingdom 收起 <<
NCT00749320	Renal Cell Carcinoma	Not Applicable	Active, not recruiting	February 2019	United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT03379012	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Recruiting	July 30, 2019	Russian Federation ... 展开 >> A.I. Kryzhanovsky Krasnoyarsk Cancer Center Recruiting Krasnoyarsk, Russian Federation Contact: Ruslan Zukov kidneycancer@yandex.ru Kidney Cancer Research Bureau Recruiting Moscow, Russian Federation Contact: Ilya Tsimafeyeu kidneycancer@yandex.ru RUDN University Recruiting Moscow, Russian Federation Contact: Yuliya Tishova kidneycancer@yandex.ru City Clinical Oncology Center Recruiting Saint Petersburg, Russian Federation Contact: Pavel Borisov kidneycancer@yandex.ru 收起 <<
NCT03571438	Kidney Cancer	Not Applicable	Recruiting	September 30, 2024	France ... 展开 >> Grenoble Alps Hospital Recruiting Grenoble, France, 38043 Contact: Jean-Luc Descotes, PU-PH 收起 <<
NCT03170180	Stomach Neoplasms	Phase 2	Recruiting	October 31, 2020	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Sung Ju Park 234106820 Principal Investigator: Jeeyun Lee, M.D., Ph.D. 收起 <<
NCT02086695	-		Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 Canada, Manitoba St. Boniface General Hospital Winnipeg, Manitoba, Canada, R2H 2A6 收起 <<
NCT01151852	-		Completed	-	-
NCT01582009	Clear Cell Renal Cell Carcinom... 展开 >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer 收起 <<	Phase 1 Phase 2	Terminated(pts off study, PI l... 展开 >>eft institute) 收起 <<	-	United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 收起 <<
NCT00876382	-		Completed	-	United States, Arkansas ... 展开 >> Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Mississippi Jackson Oncology Associates Jackson, Mississippi, United States, 39202 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 收起 <<
NCT01582204	Renal Cancer	Not Applicable	Active, not recruiting	April 2019	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 收起 <<
NCT00619268	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Completed	-	France ... 展开 >> Centre Paul Papin Angers, France Centre Hospitalier Universitaire de Besançon Besançon, France Centre Hospitalier Universitaire de Bordeaux - Hôpital St André Bordeaux, France Institut Bergonié Bordeaux, France Centre François Baclesse Caen, France Centre Jean Perrin Clermont Ferrand, France Centre Georges François Leclerc Dijon, France Centre Hospitalier de Versailles Le Chesnay, France Centre Hospitalier Universitaire de Lille - Hôpital Claude Huriez Lille, France Centre Oscar Lambret Lille, France Centre Hospitalier Universitaire DUPUTRYEN Limoges, France Centre Léon Bérard Lyon, France, 69373 Centre Hospitalier Universiariare Lyon, Hôpital Lyon Sud Lyon, France Institut Paoli Calmette Marseille, France Centre Val d'Aurelle Montpellier, France Clinique Valdegour-Centre médical Oncogard Nîmes, France Fondation Hôpital Saint Joseph Paris, France Hopital du Val de Grâce Paris, France Hôpital Européen Georges Pompidou Paris, France Centre Hospilier Universitaire de Poitiers Poitiers, France Institut Jean Godinot Reims, France Centre Eugène Marquis Rennes, France Centre René Gauducheau Saint Herblain, France Institut de Cancérologie de la Loire Saint Priest en Jarez, France Centre Hospitalier Starsbourg Strasbourg, France Hôpital FOCH Suresnes, France Institut Claudius Regaud Toulouse, France Centre Alexis Vautrin Vandoeuvre les Nancy, France Institut Gustave Roussy Villejuif, France, 94805 收起 <<
NCT00691730	Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 <<	Not Applicable	Active, not recruiting	December 2018	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 <<
NCT02208128	Renal Cell Carcinoma	Not Applicable	Unknown	February 2018	Germany ... 展开 >> Urological Department of the University Hospital Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Sascha Pahernik, PD Dr. +49 6221 56 39689 sascha.pahernik@med.uni-heidelberg.de Principal Investigator: Sascha Pahernik, PD Dr. 收起 <<
NCT02959554	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Active, not recruiting	December 2021	Austria ... 展开 >> Medizinische Universität Wien - Universitätsklinik für Innere Medizin I, Klinische Abteilung für Onkologie Wien, Austria, 1090 Germany Universitätsklinikum Essen (AöR) - Klinik und Poliklinik für Urologie / Kinderurologie und Uroonkologie Essen, Germany, 45147 收起 <<
NCT00866320	-		Completed	-	-
NCT01381614	-		Completed	-	-
NCT01582009	-		Terminated(pts off study, PI l... 展开 >>eft institute) 收起 <<	-	-
NCT00474786	Renal Cell Carcinoma	Phase 3	Completed	-	-
NCT00953446	Renal Cell Carcinoma	Not Applicable	Suspended	-	United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT00474786	-		Completed	-	-
NCT00866320	Kidney Cancer	Phase 2	Completed	-	United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 收起 <<
NCT00979381	-		Completed	-	Netherlands ... 展开 >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH 收起 <<
NCT00678288	-		Terminated	-	-
NCT01603004	-		Recruiting	May 2019	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Nitya Raj, MD 646-888-4849 Contact: Kinh Gian Do, MD, PhD 212-639-8591 Principal Investigator: Nitya Raj, MD 收起 <<
NCT00543504	Advanced Cancer	Phase 1	Active, not recruiting	October 2019	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00538772	-		Withdrawn	-	Canada, British Columbia ... 展开 >> BC Cancer Agency - Centre for Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency - Vancouver Island Victoria, British Columbia, Canada, V8R 6V5 收起 <<
NCT00678288	Carcinoma, Renal Cell	Phase 2	Terminated	-	Austria ... 展开 >> Salzburg, Austria, 5020 Wien, Austria, 1090 France Avignon, France, 84000 Bayonne, France, 64100 Bordeaux, France, 33000 Marseille, France, 13015 Marseille, France, 13385 Nantes, France, 44020 Paris, France, 75014 Paris, France, 75651 Reims, France, 51100 Strasbourg, France, 67000 Toulouse, France, 31052 Vandoeuvre Les Nancy, France, 54000 Ireland Cork, Ireland Dublin, Ireland, 24 Italy Aviano, Pordenone, Italy, 33081 Legnago, Verona, Italy, 37045 Napoli, Italy, 80131 Pavia, Italy, 27100 Perugia, Italy, 06156 Reggio Emilia, Italy, 42100 Poland Gdansk, Poland, 80-219 Lublin, Poland, 20-090 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 Spain Barcelona, Spain, 08035 Madrid, Spain, 28041 Madrid, Spain, 28046 Oviedo, Spain, 33006 Pamplona, Spain, 31008 Valencia, Spain, 46009 United Kingdom Northwood, Middlesex, United Kingdom, HA6 2RN Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE4 6BE London, United Kingdom, SW3 6JJ 收起 <<
NCT01254864	Prostate Cancer	Phase 2	Active, not recruiting	March 2019	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00457691	Metastatic Colorectal Cancer	Phase 3	Completed	-	-
NCT02688491	Renal Neoplasms ... 展开 >> Targeted Molecular Therapy 收起 <<	Not Applicable	Not yet recruiting	July 2026	-
NCT00831857	-		Completed	-	Netherlands ... 展开 >> University Medical Center Groningen Groningen, Netherlands, 9700 RB 收起 <<
NCT01524848	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Completed	-	Denmark ... 展开 >> Aarhus University Hospital, dept. of Oncology Aarhus, Denmark, DK-8000 Aarhus C Herlev Hospital, dept. of Oncology Herlev, Denmark, 2730 Finland Helsinki University Hospital, dept. of oncology Helsingfors, Finland, FI-00029 Kuopio University Hospital Cancer Center Kuopio, Finland, FI-70029 Germany Klinik für Interdisziplinäre Onkologie, Sarkomzentrum Berlin-Brandenburg Berlin, Germany, 13125 Universitätsklinikum Essen, Innere klinik und Poliklinik Essen, Germany, DE-45122 Studienzentrale chirurgische klinik, Universitäts medizin Mannheim Mannheim, Germany, DE-68167 Norway Dept of Oncology, Haukeland University Hospital Bergen, Norway, N-5021 Norwegian Radium Hospital Oslo, Norway, N-0310 Dept of Oncology, St Olav Hospital Trondheim, Norway, N-7006 Sweden Dept of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden, SE-413 45 Dept of Oncology, Linköping University Hospital Linköping, Sweden, SE-581 85 Dept of Oncology, Skane University Hospital Lund, Sweden, SE-221 85 Radiumhemmet, Karolinska University Hospital Stockholm, Sweden, SE-171 76 Dept of Oncology, Norrland University Hospital Umeå, Sweden, SE-901 85 Dept of Oncology, Academic Hospital Uppsala, Sweden, SE-751 85 收起 <<
NCT03275558	Recurrent Glioblastoma ... 展开 >> Gliosarcoma Anaplastic Gliomas 收起 <<	Phase 1	Withdrawn(Study halted prior t... 展开 >>o enrollment of first participant. (It has been determined on 2018 May 15 that the NCT03275558 study will be stopped by sponsor decision)) 收起 <<	-	Hong Kong ... 展开 >> The Hong Kong Cancer Institute Hong Kong, Hong Kong, 518031 Singapore National University Cancer Institute, Singapore, Singapore, 119074 收起 <<
NCT00869011	Renal Cell Carcinoma	Phase 3	Unknown	-	Germany ... 展开 >> Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30 Recruiting Berlin, Germany, 12200 Contact: Fernando C. Dimeo, MD +493084452098 fernando.dimeo@charite.de Principal Investigator: Fernando C. Dimeo, MD 收起 <<
NCT00734851	-		Terminated(Dose Limiting Toxic... 展开 >>ities) 收起 <<	-	-
NCT00444795	-		Completed	-	Korea, Republic of ... 展开 >> Keimyung University Dongsan Medical Center Jung-gu, Daegu, Korea, Republic of, 100-712 Daegu Catholic University Medical Center Nam-gu, Daegu, Korea, Republic of, 705-718 GangNeung Asan Hospital Gangneung-si, Gangwon-do, Korea, Republic of, 210-711 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 The Catholic University of Korea, St. Vincent's Hospital Suwon, Gyeonggi-do, Korea, Republic of, 442-723 Hwasun Hospital, Chonnam National University Cheonnam, South Jeolla Province, Korea, Republic of, 519-809 Hallym University Sacred Heart Hospital Anyang, Korea, Republic of, 431-070 Pusan National University Hospital Busan, Korea, Republic of, 602 739 Kosin University Gospel Hospital Busan, Korea, Republic of, 602-702 Dong-A University Hospital Busan, Korea, Republic of, 602-715 Dong-A University Medical Center (Dong-A University Hospital) Busan, Korea, Republic of, 602-715 Dong-A University Medical Center, Department of Medicine, Division of Hemato-Oncology Busan, Korea, Republic of, 602-715 Pusan National University Hospital Busan, Korea, Republic of, 602-739 Hwasun Hospital, Chonnam National University Cheonnam, Korea, Republic of, 519-809 Keimyung University Dongsan Hospital Daegu, Korea, Republic of, 700 712 Kyungpook National University Medical Center Daegu, Korea, Republic of, 702-210 Daegu Catholic University Medical Center (DCUMC) Daegu, Korea, Republic of, 705-718 Chungnam National University Hospital Daejeon, Korea, Republic of, 301-721 Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Inje University Ilsan Paik Hospital Goyang, Korea, Republic of, 411-706 Chosun University Hospital Gwang Joo, Korea, Republic of, 501-717 Pusan National University Hospital Gyeongsangnam-do, Korea, Republic of, 626-770 Wonkwang University School of Medicine and Hospital (WUH) Iksan -Si, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of, 400-711 Gachon University Gil Hospital Incheon, Korea, Republic of, 405-760 Chonbuk National University Hospital Jeonju, Korea, Republic of, 561-712 Yeungnam University Medical Center Nam-gu, Korea, Republic of, 705-717 Seoul National University Bundang Hospital Seongnam-si, Korea, Republic of, 463-707 Seoul National University Hospital (SNUH) Seoul, Korea, Republic of, 110-744 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Kangbuk Samsung Hospital Seoul, Korea, Republic of, 110-746 Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 120-752 Kyung Hee University Medical Center Seoul, Korea, Republic of, 130-872 KyungHee University Medical Center Seoul, Korea, Republic of, 130-872 Samsung Medical Center, Dept. of Medicine, Div. of Hematology/Oncology Seoul, Korea, Republic of, 135-710 Samsung Medical Center/Division of Hematology-Oncology, Department of Medicine Seoul, Korea, Republic of, 135-710 Gangnam Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 135-720 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Asan Medical Center/Department of Oncology Seoul, Korea, Republic of, 138-736 Asan Medical Center Seoul, Korea, Republic of, 138-736 Korea Cancer Center Hospital Seoul, Korea, Republic of, 139-706 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of, 158-710 Seoul National University Hospital Seoul, Korea, Republic of, 3080 Seoul ST. Mary's Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of, 682-714 Yonsei University Wonju College of Medicine, Wonju Christian Hospital Wonju-si, Korea, Republic of, 220-701 收起 <<
NCT00688766	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 3	Terminated(Based on Independen... 展开 >>t Data Monitoring Committee (IDMC) recommendation.) 收起 <<	-	-
NCT00457691	-		Completed	-	-
NCT02324803	Self Efficacy ... 展开 >> Adverse Drug Event Carcinoma, Renal Cell 收起 <<	Phase 2	Unknown	December 2015	China, Guangdong ... 展开 >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Mian Xie 收起 <<
NCT01381601	-		Completed	-	-
NCT00734851	Prostate Cancer	Phase 2	Terminated(Dose Limiting Toxic... 展开 >>ities) 收起 <<	-	United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21218 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 收起 <<
NCT00444795	-		Completed	-	-
NCT01289028	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 3	Completed	-	Germany ... 展开 >> Novartis Investigative Site Bad Saarow, Germany, 155226 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Halle/'Saale, Germany, 06120 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Taormina, ME, Italy, 98039 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Padova, PD, Italy, 35100 Novartis Investigative Site Aviano, PN, Italy, 33081 Novartis Investigative Site Torino, TO, Italy, 10153 收起 <<
NCT00705874	Cancer	Phase 1	Completed	-	United States, Colorado ... 展开 >> Rocky Mountain Cancer Centre Denver, Colorado, United States United States, Florida Cancer Centres of Florida Ocoee, Florida, United States, 34761 United States, Indiana Central Indiana Cancer Centres Indianapolis, Indiana, United States, 46219 United States, Nevada Comprehensive Cancer Centres of Nevada Las Vegas, Nevada, United States, 89169 United States, New York New York Oncology Hematology PC Albany, New York, United States, 12206 United States, Ohio Dayton Oncology and Hematology, PA Kettering, Ohio, United States, 45409 United States, South Carolina Cancer Centres of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology, PA Dallas, Texas, United States, 75246 Tyler Cancer Centre Tyler, Texas, United States, 75702 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Northwest Cancer Specialists - Vancouver Cancer Centre Vancouver, Washington, United States, 98684 North Star Lodge Cancer Centre Yakima, Washington, United States, 98902 收起 <<
NCT00705874	-		Completed	-	-
NCT00700258	-		Recruiting	December 1, 2023	-
NCT00717587	Kidney Cancer	Phase 2	Unknown	-	United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers 800-474-9892 收起 <<
NCT01514448	Metastatic Renal Cell Carcinom... 展开 >>a (mRCC) 收起 <<	Phase 4	Completed	-	Germany ... 展开 >> Novartis Investigative Site Chemnitz, Germany, 09130 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hannover, Germany, 30559 Novartis Investigative Site Hof, Germany, 95028 Novartis Investigative Site Kassel, Germany, 34125 Novartis Investigative Site Langen, Germany, 63225 Novartis Investigative Site Leipzig, Germany, 04357 Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Ravensburg, Germany, 88214 Novartis Investigative Site Velbert, Germany, 42551 Novartis Investigative Site Wiesbaden, Germany, 65191 Novartis Investigative Site Wolfsburg, Germany, 38440 收起 <<
NCT00486538	Advanced Renal Cell Carcinoma	Phase 2	Completed	-	United States, California ... 展开 >> Site Reference ID/Investigator# 7193 Sacramento, California, United States, 95817 United States, District of Columbia Site Reference ID/Investigator# 5243 Washington, District of Columbia, United States, 20010 United States, Illinois Site Reference ID/Investigator# 5384 Chicago, Illinois, United States, 60637 United States, Massachusetts Site Reference ID/Investigator# 11662 Boston, Massachusetts, United States, 02114 Site Reference ID/Investigator# 11663 Boston, Massachusetts, United States, 02114 Site Reference ID/Investigator# 5379 Boston, Massachusetts, United States, 02114 United States, New Hampshire Site Reference ID/Investigator# 5380 Lebanon, New Hampshire, United States, 03756-0001 United States, Pennsylvania Site Reference ID/Investigator# 5249 Philadelphia, Pennsylvania, United States, 19111 Site Reference ID/Investigator# 6278 Philadelphia, Pennsylvania, United States, 19111 Site Reference ID/Investigator# 6269 Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Site Reference ID/Investigator# 7300 Charleston, South Carolina, United States, 29425 United States, Texas Site Reference ID/Investigator# 6796 Houston, Texas, United States, 77030-4009 Canada Site Reference ID/Investigator# 6566 Vancouver, Canada, V5Z 4E6 收起 <<
NCT01514448	-		Completed	-	-
NCT02535351	Clear-cell Metastatic Renal Ce... 展开 >>ll Carcinoma 收起 <<	Phase 3	Terminated(low enrolment)	-	Italy ... 展开 >> Fondazione IRCCS Istituto Nazionale Tumori Milan, Mi, Italy, 20133 收起 <<
NCT00265798	-		Active, not recruiting	-	-
NCT00265798	Gastrointestinal Stromal Tumor	Phase 2	Active, not recruiting	-	United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT00861419	Advanced Solid Tumors	Phase 1	Completed	-	-
NCT01289028	-		Completed	-	-
NCT01227213	-		Completed	-	Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB 收起 <<
NCT03260894	Renal Cell Carcinoma (RCC)	Phase 3	Active, not recruiting	June 2020	-
NCT01091207	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Completed	-	Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135710 收起 <<
NCT00509704	-		Completed	-	Netherlands ... 展开 >> UMC St Radboud Nijmegen, Netherlands 收起 <<
NCT00482755	Breast Cancer	Phase 2	Completed	-	Canada, British Columbia ... 展开 >> British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Edmond Odette Cancer Centre at Sunnybrook Toronto, Ontario, Canada, M4N 3M5 收起 <<
NCT01370109	-		Completed	-	United States, Pennsylvania ... 展开 >> Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT01099423	Kidney Cancer	Phase 3	Active, not recruiting	May 2017	Belgium ... 展开 >> Onze Lieve Vrouw Ziekenhuis Aalst, Belgium Cliniques Universitaires St. Luc Brussels, Belgium Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium Universitair Ziekenhuis Gent Gent, Belgium Virga Jesse Hospital Hasselt, Belgium AZ Groeninghe - Campus Loofstraat Kortrijk, Belgium AZ Damiaan - Campus Sint-Jozef Oostende, Belgium Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada Canada, Quebec CHUM - Pavillon Saint-Luc Montreal,, Quebec, Canada Canada Montreal General Hospital Montreal, Canada The Ottawa Hospital, The Integrated Cancer Program- General Campus Ottawa, Canada University Health Network - Oci / Princess Margaret Hospital Toronto, Canada Diamond Health Care Centre Vancouver, Canada Italy San Camillo Forlanini Hospitals Roma, Italy Netherlands Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands Academisch Medisch Centrum - Universiteit van Amsterdam Amsterdam, Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Amsterdam, Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands Academisch Ziekenhuis Maastricht Maastricht, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands Universitair Medisch Centrum - Academisch Ziekenhuis Utrecht, Netherlands United Kingdom Royal United Hospital Bath, United Kingdom University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre Bristol, United Kingdom St. James'S University Hospital Leeds, United Kingdom Barts and The London NHS Trust - St. Bartholomew'S Hospital London, United Kingdom Imperial College Healthcare NHS Trust - Charing Cross Hospital London, United Kingdom Christie NHS Foundation Trust Manchester, United Kingdom Singelton Hospital Swansea, United Kingdom 收起 <<
NCT01876212	Metastatic Melanoma	Phase 2	Active, not recruiting	June 6, 2019	United States, Pennsylvania ... 展开 >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 收起 <<
NCT02645149	Melanoma	Phase 4	Not yet recruiting	August 2021	Australia, New South Wales ... 展开 >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez 612 9911 7200 maria.gonzalez@melanoma.org.au Principal Investigator: John Thompson Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez +612 9911 7200 maria.gonzalez@melanoma.org.au Contact: Alex Menzies +612 9911 7200 info@melanoma.org.au Sub-Investigator: Georgina Long Principal Investigator: Alex Menzies 收起 <<
NCT00610012	-		Active, not recruiting	August 2020	Germany ... 展开 >> iOMEDICO Freiburg, Germany 收起 <<
NCT02551718	Acute Leukemia of Ambiguous Li... 展开 >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia 收起 <<	Not Applicable	Recruiting	-	United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker 收起 <<
NCT01246817	Renal Cell Cancer	Phase 2	Unknown	-	Netherlands ... 展开 >> University Medical Centre Nijmegen Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Principal Investigator: C.M.L. van Herpen, Md PhD 收起 <<
NCT01758575	-		Terminated	-	Netherlands ... 展开 >> VU University Medical Center Amsterdam, Netherlands, 1081HV 收起 <<
NCT00877045	-		Completed	-	United States, Florida ... 展开 >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Georgia Cancer Specialists Atlanta, Georgia, United States, 30341 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 收起 <<
NCT03419572	-		Recruiting	January 5, 2021	-
NCT02776644	-		Completed	-	-
NCT00601120	Renal Cell Carcinoma	Not Applicable	Withdrawn(This protocol was ne... 展开 >>ver officially opened and no patients were recruited.) 收起 <<	-	United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 收起 <<
NCT01984931	Nausea Vomiti... 展开 >>ng 收起 <<	Phase 3	Unknown	December 2013	Korea, Republic of ... 展开 >> Chungmu General Hopsital Recruiting Seoul, Yeongdeungpo-gu, Korea, Republic of, 150-034 Contact: Sang Hoon Lhee, MD, Phd +82 (2) 2068/4525 cmirb@naver.com Principal Investigator: Paolo Alan B Tabar, MD 收起 <<
NCT02208583	Hormone Refractory Prostate Ca... 展开 >>ncer 收起 <<	Not Applicable	Unknown	December 2016	China, Tianjin ... 展开 >> Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Wang HaiTao, Ph.D +86-18630955984 peterrock2000@126.com Principal Investigator: Wang HaiTao, Ph.D 收起 <<
NCT03387514	Renal Cell Carcinoma	Phase 2	Recruiting	January 15, 2022	United States, Wisconsin ... 展开 >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53705 Contact: Cancer Connect 800-622-8922 cancerconnect@uwcarbone.wisc.edu 收起 <<
NCT01636908	Cancer Advanc... 展开 >>ed Solid Tumors 收起 <<	Not Applicable	Active, not recruiting	-	Netherlands ... 展开 >> VUMedical Center Amsterdam, Netherlands, 1081 HV 收起 <<
NCT02142036	Metastatic Cancer	Phase 2	Active, not recruiting	January 2022	Norway ... 展开 >> Akershus University Hospital Lillestrøm, Norway, 1478 The Norwegian Radium Hospital Oslo, Norway, 0379 收起 <<
NCT03413176	-		Completed	-	France ... 展开 >> AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France, 75013 收起 <<
NCT00698659	-		Terminated	-	Singapore ... 展开 >> National University Hospital Singapore, Singapore 收起 <<
NCT03297606	Lymphoma, Non-Hodgkin ... 展开 >> Multiple Myeloma Advanced Solid Tumors 收起 <<	Phase 2	Recruiting	September 2021	Canada, British Columbia ... 展开 >> BCCA - Vancouver Cancer Centre Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Daniel John Renouf 604 877-6000 ext 672357 Canada, Ontario London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Stephen Welch 519 685-8640 Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: John Hilton 613 737-7700 ext 70179 University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Lillian Siu 416 946-2911 Canada, Quebec The Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Cristiano Ferrario 514 398-8307 收起 <<
NCT01200134	Anaplastic Glioma	Phase 2	Completed	-	France ... 展开 >> Caen University Hospital Caen, France, 14033 收起 <<
NCT02747173	-		Terminated	-	Spain ... 展开 >> Hospital Universitario central de Asturias Oviedo, Asturias, Spain, 33011 Hospital de Donostia San Sebastián, Guipuzcoa, Spain, 20080 Complejo Hospitalario Univ de Santiago de Compostela Santiago de Compostela, La Coruña, Spain, 15706 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Univ de Vigo Vigo, Pontevedra, Spain, 36204 Consorcio Hospitalario Parc Tauli Barcelona, Spain, 08208 Complejo Hospitalario de León Leon, Spain, 24071 Hospital Univ Lucus Augusti Lugo, Spain, 27003 Complejo Hospitalario de Ourense Ourense, Spain, 32005 Instituto Valenciano de Oncologia Valencia, Spain, 46009 Hospital Universitario La Fe Valencia, Spain, 46026 Hospital Miguel Servet Zaragoza, Spain, 50009 收起 <<
NCT01858441	Pharmacogenetic Study	Not Applicable	Active, not recruiting	December 2020	France ... 展开 >> Centre Antoine Lacassagne Nice, France, 06000 收起 <<
NCT02228954	-		Active, not recruiting	December 2019	Netherlands ... 展开 >> VU University Medical Center Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands Radboudumc Nijmegen, Netherlands, 6525GA 收起 <<
NCT02086734	-		Completed	-	Germany ... 展开 >> Urologische Klinik und Poliklinik der Universität München München, Bavaria, Germany, 81377 收起 <<
NCT00498966	Kidney Cancer	Phase 2	Completed	-	United States, Kentucky ... 展开 >> Investigative Site Louisville, Kentucky, United States, 40202 United States, New Jersey Investigative Site Morristown, New Jersey, United States, 07962 United States, New York Investigative Site Armonk, New York, United States, 10504 收起 <<
NCT01810744	Metastatic Colorectal Cancer ... 展开 >> Glioblastoma Bevacizumab Capillaroscopy 收起 <<	Not Applicable	Active, not recruiting	June 2018	France ... 展开 >> Centre Georges François Leclerc Dijon, France, 21079 收起 <<
NCT01498458	Metastatic Breast Cancer	Phase 1	Completed	-	Germany ... 展开 >> GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 收起 <<
NCT01498458	-		Completed	-	-
NCT03091465	-		Completed	-	-
NCT02847377	Carcinoma, Non-Small-Cell Lung	Early Phase 1	Recruiting	March 27, 2019	France ... 展开 >> CGFL Recruiting Dijon, France, 21079 收起 <<
NCT01538238	Locally Advanced or Metastatic... 展开 >> Non-clear Cell Type Renal Cell Carcinoma 收起 <<	Phase 2	Completed	-	Korea, Republic of ... 展开 >> Samsung medical Center Seoul, Korea, Republic of 收起 <<
NCT02788201	Urothelial Carcinoma ... 展开 >> Bladder Cancer Urinary Bladder Neoplasms 收起 <<	Phase 2	Recruiting	July 1, 2020	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 <<
NCT02044354	Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 3	Active, not recruiting	April 2018	France ... 展开 >> Gustave Roussy Villejuif, Val de Marne, France, 94805 收起 <<
NCT01372813	-		Terminated(Terminated for insu... 展开 >>fficient accrual.) 收起 <<	-	-
NCT02056587	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 4	Completed	-	Russian Federation ... 展开 >> Tatarstan Regional Cancer Center Kazan, Tatarstan, Russian Federation, 420029 Altai Regional Cancer Center Barnaul, Russian Federation N.N. Blokhin Russian Cancer Research Center Moscow, Russian Federation, 115478 收起 <<
NCT03024437	Metastatic Cancer ... 展开 >> Renal Cancer 收起 <<	Phase 1 Phase 2	Recruiting	January 31, 2020	United States, Indiana ... 展开 >> Indiana University Health Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Sheila Dropcho, RN 317-278-4191 marlmoor@iu.edu Principal Investigator: Roberto Pili, MD Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Sheila Dropcho, RN 317-278-4191 sdropcho@iupui.edu Principal Investigator: Roberto Pili, MD United States, Pennsylvania University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Julia Wolinkski 215-360-0928 julia.wolinksi@uphs.upenn.edu Principal Investigator: Vivek Narayan, MD 收起 <<
NCT01466504	-		Terminated(Accrual did not mee... 展开 >>t expectations. Over nearly 2 years just 4 subjects were treated on study. The goal of 30 subjects was not attainable.) 收起 <<	-	United States, New Hampshire ... 展开 >> Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, Vermont White River Junction VA Medical Center White River Junction, Vermont, United States, 05009 收起 <<
NCT03229512	Hand Foot Skin Reaction	Early Phase 1	Recruiting	December 2018	United States, Illinois ... 展开 >> Department of Dermatology, Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD 312-695-8106 jennifer.choi@northwestern.edu Contact: Linda Serrano, MD 312-503-5903 linda.serrano@northwestern.edu Principal Investigator: Jennifer N Choi, MD Sub-Investigator: Linda Serrano, MD Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD 312-695-8106 jennifer.choi@northwestern.edu Contact: Linda Serrano, MD 312-503-5903 linda.serrano@northwestern.edu Principal Investigator: Jennifer N Choi, MD Sub-Investigator: Linda Serrano, MD 收起 <<
NCT02877368	-		Completed	-	France ... 展开 >> Chu de Reims Reims, France, 51092 收起 <<
NCT01372813	Advanced Clear Cell Renal Carc... 展开 >>inoma 收起 <<	Phase 2	Terminated(Terminated for insu... 展开 >>fficient accrual.) 收起 <<	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT02712112	Gastrointestinal Stromal Tumor... 展开 >>s (GISTs) 收起 <<	Phase 2	Recruiting	December 2018	Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Min-Hee Ryu, MD., Ph.D. +82-10-5285-9492 miniryu@amc.seoul.kr Principal Investigator: Min-Hee Ryu, M.D., Ph.D. 收起 <<
NCT00715182	Advanced/ Metastatic Renal Cel... 展开 >>l Cancer 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> Novartis Investigative Site San Francisco, California, United States United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98109-1023 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site München, Germany, 81675 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Spain Novartis Investigative Site Madrid, Spain, 28041 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 收起 <<
NCT01339962	-		Completed	-	Denmark ... 展开 >> University of Copenhagen Herlev Hospital Herlev, Denmark, 2730 收起 <<
NCT02599779	Stage IV Renal Cell Cancer AJC... 展开 >>C V7 收起 <<	Phase 2	Recruiting	March 2021	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Richard Lee-Ying, MD richard.lee-ying@albertahealthservices.ca Principal Investigator: Richard Lee-Ying, MD Canada, Ontario Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Georg A. Bjarnason, MD 416-480-5847 georg.bjarnason@sunnybrook.ca Contact: Nesan Bandali, RN 416-480-5000 ext 82139 nesan.bandali@sunnybrook.ca Principal Investigator: Georg A. Bjarnason, MD Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Aaron Hansen, MD 416-946-4501 aaron.hansen@uhn.ca Principal Investigator: Aaron Hansen, MD 收起 <<
NCT00782275	-		Completed	-	-
NCT02558387	Recurrent or Metastatic Saliva... 展开 >>ry Gland Cancer of the Head and Neck 收起 <<	Phase 2	Unknown	January 2017	Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 <<
NCT01798446	Renal Cell Carcinoma ... 展开 >> Nonclear Cell Temsirolimus Resistance 收起 <<	Phase 2	Unknown	December 2016	Korea, Republic of ... 展开 >> Seou National University Hospital Recruiting Seoul, Korea, Republic of, 110744 Contact: Se-Hoon Lee, MD, PhD 82220722199 shlee119@snu.ac.kr Principal Investigator: Se-Hoon Lee, MD, PhD Sub-Investigator: Dae Seog Heo, MD, PhD Sub-Investigator: Dong-Wan Kim, MD, PhD Sub-Investigator: Tae Min Kim, MD, PhD Sub-Investigator: Bhumsuk Keam, MD 收起 <<
NCT02693535	Lymphoma, Non-Hodgkin ... 展开 >> Multiple Myeloma Advanced Solid Tumors 收起 <<	Phase 2	Recruiting	-	-
NCT00782275	Renal Cell Carcinoma ... 展开 >> Kidney Cancer 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Tennessee Vanderbilt Univeristy Medical Center Nashville, Tennessee, United States, 37232 收起 <<
NCT02113826	Metastatic Alveolar Soft Part ... 展开 >>Sarcoma 收起 <<	Phase 2	Terminated(Low accrual rate)	-	Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 <<
NCT02816515	-		Completed	-	Hungary ... 展开 >> Department of Oncological Internal Medicine and Clinical Pharmacology "C", National Institute of Oncology Hungary Budapest, Hungary, 1026 National Koranyi Institute of TB and Pulmonology Budapest, Hungary, 1121 National Institute of Oncology, Department of Radiotherapy 7-9 Ráth György u. Budapest, Hungary 收起 <<
NCT01342627	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Terminated(low enrollment rate... 展开 >>) 收起 <<	-	Italy ... 展开 >> Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 收起 <<
NCT01491672	Metastatic Renal Cell Carcinom... 展开 >>a 收起 <<	Phase 2	Completed	-	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center NY, New York, United States, 90033 Argentina Novartis Investigative Site Rio Negro, Viedma, Argentina, 8500 Novartis Investigative Site Tucuman, Argentina, T4000 Brazil Novartis Investigative Site Florianopolis, SC, Brazil, 88034-000 Novartis Investigative Site Barretos, SP, Brazil, 14784-400 Novartis Investigative Site São Paulo, SP, Brazil, 01246-000 Novartis Investigative Site São Paulo, SP, Brazil, 01509-900 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1784 China, Beijing Novartis Investigative Site Beijing, Beijing, China, 100730 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Guangzhou, China, 510060 Novartis Investigative Site Shanghai, China, 200032 Russian Federation Novartis Investigative Site Leningrad Region, Russia, Russian Federation, 188663 Novartis Investigative Site Moscow, Russia, Russian Federation, 125284 Novartis Investigative Site Nizhny Novgorod, Russia, Russian Federation, 603001 Novartis Investigative Site Obninsk, Russia, Russian Federation, 249036 收起 <<
NCT02465060	Advanced Malignant Solid Neopl... 展开 >>asm Bladder Carcinoma Breast Carcinoma Cervical Carcinoma Colon Carcinoma Colorectal Carcinoma Endometrial Carcinoma Esophageal Carcinoma Gastric Carcinoma Glioma Head and Neck Carcinoma Kidney Carcinoma Liver and Intrahepatic Bile Duct Carcinoma Lung Carcinoma Lymphoma Malignant Uterine Neoplasm Melanoma Ovarian Carcinoma Pancreatic Carcinoma Plasma Cell Myeloma Prostate Carcinoma Rectal Carcinoma Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Cervical Carcinoma Recurrent Colon Carcinoma Recurrent Colorectal Carcinoma Recurrent Esophageal Carcinoma Recurrent Gastric Carcinoma Recurrent Glioma Recurrent Head and Neck Carcinoma Recurrent Liver Carcinoma Recurrent Lung Carcinoma Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Melanoma Recurrent Ovarian Carcinoma Recurrent Pancreatic Carcinoma Recurrent Plasma Cell Myeloma Recurrent Prostate Carcinoma Recurrent Rectal Carcinoma Recurrent Skin Carcinoma Recurrent Thyroid Gland Carcinoma Recurrent Uterine Corpus Carcinoma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Plasma Cell Myeloma Skin Carcinoma Thyroid Gland Carcinoma Uterine Corpus Cancer 收起 <<	Phase 2	Recruiting	-	-
NCT01491672	-		Completed	-	-
NCT03556384	Gastrointestinal Stromal Tumor... 展开 >>s Sdh GIST Cancer 收起 <<	Phase 2	Recruiting	September 2024	United States, California ... 展开 >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Elaine Eng e1eng@ucsd.edu Principal Investigator: Adam M Burgoyne, MD, PhD Sub-Investigator: Jason K Sicklick, MD 收起 <<
NCT02751827	-		Recruiting	February 2019	France ... 展开 >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD Principal Investigator: Antoine ITALIANO, MD,PhD Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY, MD, PhD Principal Investigator: Jean-Yves BLAY, MD, PhD 收起 <<
NCT02789137	-		Recruiting	October 30, 2018	Spain ... 展开 >> Hospital Arquitecto Marcide de Ferrol Recruiting Ferrol, A Coruña, Spain, 15405 Hospital Asil de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Hospital Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Hospital Galdakano Recruiting Usansolo, Bizkaia, Spain, 48960 Complejo Hospitalario la Mancha Centro Recruiting Alcazar de San Juan, Ciudad REAL, Spain, 13600 Hospital Universitari Son Espases Recruiting Palma, Mallorca, Spain, 07120 H. Universitario Infanta Cristina Recruiting Badajoz, Spain, 06006 Hospital Vall de Hebrón Recruiting Barcelona, Spain, 08035 Hospital Universitario Ciudad Real Recruiting Ciudad Real, Spain, 13005 H. Reina Sofía de Cordoba Recruiting Córdoba, Spain, 14004 Hospital de Cabueñes Not yet recruiting Gijón, Spain, 33394 ICO Girona (Hospital Dr.Josep Trueta) Recruiting Girona, Spain, 17007 Hospital Universitario de Guadalajara Not yet recruiting Guadalajara, Spain, 19002 Complejo Hospitalario de Jaén Recruiting Jaén, Spain, 23007 Complejo Hospitalario de León Recruiting León, Spain, 24071 Complejo Hospitalario Ourense. Hospital Santa María Nai Recruiting Ourense, Spain, 32005 Hospital General de Asturias Not yet recruiting Oviedo, Spain, 33011 Complejo Hospitalario de Navarra Recruiting Pamplona, Spain, 31008 Hospital Universitario Canarias Not yet recruiting Santa Cruz de Tenerife, Spain, 38320 Hospital de Sant Pau i Santa Tecla Recruiting Tarragona, Spain, 43003 Hospital Virgen de la Salud Recruiting Toledo, Spain, 45071 Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46011 H Clínico Zaragoza Recruiting Zaragoza, Spain, 50009 收起 <<
NCT01390519	-		Completed	-	Norway ... 展开 >> Novartis Investigative Site Kristiansand, Norway, 4615 Novartis Investigative Site Tromsø, Norway, 9038 Novartis Investigative Site Trondheim, Norway, 7006 收起 <<
NCT03353753	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 3	Active, not recruiting	December 2020	-
NCT01370980	-		Unknown	September 2014	Switzerland ... 展开 >> Policlinique Médicale Universitaire and Centre pluridisciplinaire d'oncologie, CHUV Recruiting Lausanne, Vaud, Switzerland, 1010 Contact: Bugnon Olivier +41 21 314 48 48 Olivier.Bugnon@hospvd.ch Contact: Schneider Marie-Paule +41 21 314 48 46 Marie-Paule.Schneider@hospvd.ch 收起 <<
NCT01377298	Head and Neck Squamous Cell Ca... 展开 >>rcinoma 收起 <<	Phase 2	Unknown	May 2014	Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ruey-Long Hong, MD +886 2 23123456 ext 67510 rlhong@ntu.edu.tw Sub-Investigator: Jo-Pai Chen, MD Principal Investigator: Ruey-Long Hong, MD 收起 <<
NCT00633295	Gastrointestinal Stromal Tumor... 展开 >>s (GIST) 收起 <<	Phase 2	Completed	-	Israel ... 展开 >> Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Tel Aviv, Israel Novartis Investigative Site Tel Hashomer, Israel 收起 <<
NCT02338570	Renal Cell Carcinoma	Phase 4	Terminated(Stopped on November... 展开 >> 16th 2016, because of recruitment failure.) 收起 <<	-	Italy ... 展开 >> Spedali Civili Brescia, Italy Ospedale A Perrino Brindisi, Italy Istituto Europeo di Oncologia Milano, Italy Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale Napoli, Italy AOU Maggiore della Carità Novara, Italy Casa di Cura La Maddalena Palermo, Italy Unicampus Biomedico Roma, Italy AOU San Giovanni di Dio e Ruggi D'Aragona Salerno, Italy 收起 <<
NCT02700568	Carcinoma, Renal Cell ... 展开 >> Clear Cell Renal Cell Carcinoma 收起 <<	Phase 2	Recruiting	August 2018	Russian Federation ... 展开 >> Demchenkova Marina Viktorovna Recruiting Irkutsk, Russian Federation Semenov Andrey Vladimirovich Recruiting Ivanovo, Russian Federation Mikhailova Nadezhda Vasilievna Recruiting Kazan, Russian Federation Eskerov Kurban Abdulmutalibovich Active, not recruiting Kirov, Russian Federation Zukov Ruslan Aleksandrovich Recruiting Krasnoyarsk, Russian Federation Ovchinnikova Elena Georgievna Recruiting Nizhny Novgorod, Russian Federation Guseva Irina Vasilievna Recruiting Penza, Russian Federation Vladimirova Lyubov Yur'evna Active, not recruiting Rostov-on-Don, Russian Federation Zolotoreva Tatiana Gennadievna Recruiting Samara, Russian Federation Katkov Alexey Aleksandrovich Active, not recruiting Saratov, Russian Federation Ivannikov Andrey Andreyevich Recruiting Tambov, Russian Federation Usynin Evgeny Anatolievich Recruiting Tomsk, Russian Federation Evstegneyeva Irina Vladimirovna Recruiting Tver, Russian Federation Khmelevsky Andrey Anatolievich Recruiting Ufa, Russian Federation Gurina Ludmila Ivanovna Active, not recruiting Vladivostok, Russian Federation 收起 <<
NCT03185039	Kidney Cancer	Not Applicable	Recruiting	November 29, 2020	France ... 展开 >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: GENRE Dominique, MD 33 (0)4 91 22 37 78 drci.up@ipc.unicancer.fr Contact: Isabelle Boquet, PhD 33 (0)4 91 22 37 78 drci.up@ipc.unicancer.fr Principal Investigator: GRAVIS Gwénaëlle, MD 收起 <<
NCT00923130	-		Completed	-	-
NCT02921724	Cancer Oral D... 展开 >>rug Administration 收起 <<	Not Applicable	Recruiting	May 2019	Italy ... 展开 >> Azienda Ospedaliera Papa Giovanni XXIII, Bergamo Recruiting Bergamo, Italy, 24127 Contact: Carlo Tondini, MD Principal Investigator: Carlo Tondini, MD Irst-Irccs Recruiting Meldola (FC), Italy, 47014 Contact: Alessandro Passardi, MD +39 0543 739238 alessandro.passardi@irst.emr.it Principal Investigator: Alessandro Passardi, MD Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento Recruiting Trento, Italy, 38123 Contact: Mimma Rizzo, MD Principal Investigator: Mimma Rizzo, MD 收起 <<
NCT00448721	Renal Cell Carcinoma	Phase 2	Completed	-	United States, California ... 展开 >> Investigative Site Duarte, California, United States, 91010 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Investigative Site Nashville, Tennessee, United States, 37232 收起 <<
NCT02483247	Cancer	Phase 1 Phase 2	Active, not recruiting	-	United States, Indiana ... 展开 >> Parkview Research Center Fort Wayne, Indiana, United States Indiana University Health Goshen Goshen, Indiana, United States, 46526 Indiana University -Ball Indianapolis, Indiana, United States Indiana University-SCC Indianapolis, Indiana, United States United States, Louisiana Louisiana State Univesity New Orleans, Louisiana, United States United States, Virginia US Oncology Research Fairfax, Virginia, United States Canada, Ontario Ottawa Hospital Research Institute Ottawa, Ontario, Canada Princess Margaret Cancer Centre Toronto, Ontario, Canada 收起 <<
NCT01265810	Oral Complaints ... 展开 >> Renal Cell Carcinoma Hepatocellular Carcinoma Gastrointestinal Stromal Tumors 收起 <<	Phase 3	Completed	-	Netherlands ... 展开 >> The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Centre (LUMC) Leiden, Netherlands, 2300 RC 收起 <<
NCT01793636	Metastatic Clear Cell Renal Ca... 展开 >>rcinoma 收起 <<	Phase 2	Terminated(Inferior efficacy o... 展开 >>f study drug in renal indication.) 收起 <<	November 2015	United Kingdom ... 展开 >> Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Royal Sussex County Hospital Brighton, United Kingdom, BN2 5BE University Hospitals Coventry & Warwickshire NHS Trust Coventry, United Kingdom, CV2 2DX Beatson West of Scotland Cancer Center Glasgow, United Kingdom, G12 0YN St. James' Hospital Leeds, United Kingdom, LS9 7TF Barts Health NHS Trust London, United Kingdom, EC1A 6BE Royal Free London Hospital London, United Kingdom, NW3 2QG Southampton General Hospital Southampton, United Kingdom, SO16 6YD Southend University Hospital NHS Foundation Trust Westcliff-On-Sea, United Kingdom, SS0 0RY 收起 <<
NCT00923130	Renal Cell Carcinoma	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, South Carolina University of South Carolina Charleston, South Carolina, United States, 29425 收起 <<
NCT01700699	-		Unknown	October 2013	Italy ... 展开 >> Department of Medicine and Surgery, Univeristy of Salerno Recruiting Baronissi, Salerno, Italy, 84081 Contact: Mario Vitale, MD +39 089672539 mavitale@unisa.it Principal Investigator: Mario Vitale, MD 收起 <<
NCT01714765	Metastatic Clear Cell Renal Ca... 展开 >>ncer 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> Barts Health NHS Trust London, United Kingdom, EC1M 7BE 收起 <<
NCT00767819	Progressive Sarcoma	Phase 2	Completed	-	Germany ... 展开 >> Novartis Investigative Site Bad Saarow, Germany, 15526 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Italy Novartis Investigative Site Milano, MI, Italy, 20133 收起 <<
NCT03598816	Renal Cell Carcinoma	Phase 2	Not yet recruiting	November 30, 2021	United States, Missouri ... 展开 >> Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: James J Hsieh, M.D., Ph.D. 314-273-1688 jhsieh@wustl.edu Principal Investigator: James J Hsieh, M.D., Ph.D. Sub-Investigator: Vivek Arora, M.D., Ph.D. Sub-Investigator: William E Gillanders, M.D. Sub-Investigator: Eric Knoche, M.D. Sub-Investigator: Jingqin (Rosy) Luo, Ph.D. Sub-Investigator: Peter Oppelt, M.D. Sub-Investigator: Russell Pachynski, M.D. Sub-Investigator: Joel Picus, M.D. Sub-Investigator: Bruce Roth, M.D. Sub-Investigator: Malachi Griffith, Ph.D. Sub-Investigator: Obi Griffith, Ph.D. 收起 <<
NCT01649180	-		Terminated(Closed due to prolo... 展开 >>nged enrollment timelines) 收起 <<	-	-
NCT02533258	-		Completed	-	-
NCT02533258	-		Completed	-	-
NCT01105364	Kidney Cancer ... 展开 >> Metastatic Cancer 收起 <<	Not Applicable	Unknown	-	France ... 展开 >> Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Contact Person 33-2-4747-4776 收起 <<
NCT01649180	Renal Cell Carcinoma	Phase 2	Terminated(Closed due to prolo... 展开 >>nged enrollment timelines) 收起 <<	-	United States, Nebraska ... 展开 >> Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, Ohio Cleveland Clinic, Taussig Cancer Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT02048371	Liposarcoma O... 展开 >>steogenic Sarcoma Ewing/Ewing-like Sarcoma Rhabdomyosarcoma 收起 <<	Phase 2	Recruiting	December 2020	United States, California ... 展开 >> City of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Torie Fechner 626-256-4673 tfechner@coh.org Principal Investigator: Warren Chow, MD Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Magnolia Manzano 323-361-8156 mmanzano@chla.usc.edu Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Victoria Chua 310-552-9999 vchua@sarcomaoncology.com Principal Investigator: Sant Chawla, MD Stanford University Recruiting Stanford, California, United States, 94305 Contact: Maria Ahern 650-725-6413 mahern@stanford.edu Principal Investigator: Kristen Ganjoo, MD United States, Florida Mayo Clinic - Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO 904-953-7292 Attia.Steven@mayo.edu Principal Investigator: Steven Attia, DO H. Lee Moffitt Terminated Tampa, Florida, United States, 33612 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Rasima Cehic 312-695-2082 rasima.cehic@northwestern.edu Principal Investigator: Mark Agulnik, MD United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Michele Niland 317-278-0778 mniland@iupui.edu Principal Investigator: Daniel Rushing, MD United States, Massachusetts Dana Farber/Partners Cancer Care Terminated Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Minnesota Recruiting Rochester, Minnesota, United States, 55905 Contact: Elizabeth Smith 507-293-3817 Smith.Elizabeth6@mayo.edu Principal Investigator: Scott Okuno, MD United States, North Carolina Carolinas Healthcare System Recruiting Charlotte, North Carolina, United States, 28203 Contact: Michelle Treadwell 980-442-2332 Michelle.Treadwell@carolinashealthcare.org Principal Investigator: Michael Livingston, MD Duke University Recruiting Durham, North Carolina, United States, 27705 Contact: Colleen Piechocki 919-681-1883 colleen.piechocki@duke.edu Principal Investigator: Richard Riedel, MD United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43202 Contact: Comprehensive Cancer Center 800-293-5066 Jamesline@osumc.edu Principal Investigator: David Liebner, MD United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: David Boody-Alter 503-418-9655 boodyalt@ohsu.edu Principal Investigator: Lara Davis, MD United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Melissa Sindler 615-875-0060 melissa.m.sindler@vanderbilt.edu Principal Investigator: Vicky Keedy, MD United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Justin Parker 801-587-4702 justin.parker@hci.utah.edu Principal Investigator: Jennifer Wright, MD United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Roxanne Moore 206-288-6425 romoore@seattlecca.org Principal Investigator: Elizabeth Loggers, MD, PhD 收起 <<
NCT02616185	Prostatic Neoplasms	Phase 1	Recruiting	March 15, 2021	United States, Connecticut ... 展开 >> Smilow Cancer Hospital at Yale-New Haven Recruiting New Haven, Connecticut, United States, 06510 United States, Maryland National Institutes of Health Active, not recruiting Bethesda, Maryland, United States, 20892-1196 National Institutes of Health Clinical Center Active, not recruiting Bethesda, Maryland, United States, 20892 United States, Nebraska GU Research Network Recruiting Omaha, Nebraska, United States, 68130 United States, Nevada Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 United States, New York Memorial Sloan-Kettering Cancer Center 53rd Street Recruiting New York, New York, United States, 10022 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center Recruiting New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Investigational Chemotherapy Services Recruiting Durham, North Carolina, United States, 27710 United States, Pennsylvania UPMC Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 UPMC CancerCenter- Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 收起 <<
NCT00640692	-		Terminated(Insufficient enroll... 展开 >>ment) 收起 <<	April 2011	-
NCT02342600	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Withdrawn(Supporting company w... 展开 >>ithdrew interest) 收起 <<	-	-
NCT03171389	GIST, Malignant ... 展开 >> KIT Exon 13 Mutation KIT Gene Mutation 收起 <<	Phase 2	Recruiting	September 22, 2020	Germany ... 展开 >> West German Cancer Center Recruiting Essen, NRW, Germany, 45122 Principal Investigator: Sebastian Bauer, Prof. Dr. 收起 <<
NCT02071719	-		Terminated	October 2017	Netherlands ... 展开 >> VU Medical Center Amsterdam, Noord Holland, Netherlands, 1081 HV 收起 <<

CAS号	341031-54-7
分子式	C₂₆H₃₃FN₄O₇
分子量	532.561

别名	苹果酸苏尼替尼 ;SU 11248 Malate;Sunitinib (malate);SU11248
运输	蓝冰

苹果酸舒尼替尼 /Sunitinib Malate 99%+

Sunitinib Malate 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Sunitinib Malate 质控信息

Sunitinib Malate 生物活性

Sunitinib Malate 细胞研究

Sunitinib Malate 动物研究

Sunitinib Malate 临床研究

Sunitinib Malate 参考文献

Sunitinib Malate 实验方案

Sunitinib Malate 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

苹果酸舒尼替尼 /Sunitinib Malate 99%+

Sunitinib Malate 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Sunitinib Malate 质控信息

Sunitinib Malate 生物活性

Sunitinib Malate 细胞研究

Sunitinib Malate 动物研究

Sunitinib Malate 临床研究

Sunitinib Malate 参考文献

Sunitinib Malate 实验方案

Sunitinib Malate 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Sunitinib Malate 纯度/质量文件产品仅供科研